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 The study of neurogenesis is important for understanding the causes of 
many developmental defects, and crucial for the prevention and treatment of 
neuronal degeneration and injury.  The olfactory system is an excellent model for 
the study of neurogenesis due to its unique ability to continuously regenerate 
olfactory sensory neurons (OSNs), even in adults.  Pituitary adenylate cyclase-
activating polypeptide (PACAP) functions in many aspects of neurogenesis and 
is present in the olfactory epithelium (OE).  We examined the role of PACAP, in 
vivo, in the development and regeneration of the OE by comparing PACAP 
knock-out (KO) and wild-type (WT) mice.  In early postnatal development, 
proliferation levels are reduced in PACAP KO mice but the number of OSNs is 
not different from WT mice.  By 1 week of age, no differences between PACAP 
KO and WT mice were observed.  Given that other growth factors may be 
present during development and could compensate for the absence of PACAP, 
we also examined adult OE.  Although adult PACAP KO mice have normal food 
odorant detection, the OE exhibits decreased epithelial thickness due to loss of 
cells.  However, immunostaining revealed no differences in OSN numbers 
between PACAP KO and WT mice, although expression levels for markers of 
OSNs were increased.  Surprisingly, PACAP KO mice show increased 
proliferation compared to WT mice.  Injury-induced degradation, resulting in 
  iv 
regeneration of the OE, was also examined in adult PACAP KO and WT mice.  
Immediately after chemical insult, PACAP KO mice exhibited more inflammation 
than WT mice.  A faster decline in OSNs, leading to quicker onset of anosmia, 
was seen in PACAP KO mice.  In addition, PACAP KO mice recovered from 
anosmia more quickly, likely due to increased proliferation levels before insult.  
However, 1 week following insult there were no differences between PACAP KO 
and WT mice, and both groups were recovered functionally after 2 weeks.  We 
conclude that PACAP has a minor influence promoting proliferation during OE 
development.  PACAP is not required for adult proliferation, but is required for the 
survival and maintenance of adult OE.  This study suggests PACAP may be 
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 The study of neurogenesis is crucial to understanding how developmental 
defects arise, and necessary to provide therapeutic targets against neuronal 
degeneration and injury.  Pituitary adenylate cyclase-activating polypeptide 
(PACAP) could be a therapeutic target given that PACAP plays many roles in 
neurogenesis including proliferation, differentiation, and survival. Furthermore, 
PACAP is found within the olfactory system.  Unlike other systems, the olfactory 
system is remarkable for maintaining adult neurogenesis. This neurogenesis 
depends on the interplay of many molecular mechanisms that could involve 
PACAP.  The capacity to regenerate makes the olfactory epithelium (OE) an 
excellent model for the study of the role of PACAP in neurogenesis.  This 
dissertation will explore PACAP in neonatal and adult neurogenesis by means of 
the following questions: 1) What is the role of PACAP on OE development?  2) 
What is the role of PACAP in adult OE maintenance?  3) What role does PACAP 
play in adult regeneration of OE after injury?  We hypothesize that PACAP plays 
a trophic, or supportive, role in neurogenesis. Furthermore, we hypothesize that 
a lack of PACAP will lead to reduced numbers of cells in the OE.  The aim of this 
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dissertation is to further our understanding of the role of PACAP in a developing 
and regenerating sensory system, which may aid in our understanding of 
developmental defects and potential therapies. 
 
The Role of PACAP in Neurogenesis 
PACAP regulates gene transcription 
 PACAP is expressed as either a 27 or 38 amino acid peptide and is part of 
the vasointestinal peptide-glucagon secretin peptide superfamily.  Both forms of 
PACAP bind to 3 receptors: PAC1, VPAC1, and VPAC2.  The PAC1 receptor 
has been shown to mediate the majority of effects of PACAP on neuronal 
proliferation, differentiation, and survival (Lu et al., 1998; Nicot et al., 2002; Mei et 
al., 2004; Mercer et al., 2004; Ravni et al., 2006).  PACAP and the PAC1 
receptor are widely expressed in neurogenic regions, such as the olfactory bulb, 
hippocampus, and cerebellum, in both embryonic and adult animals (Sheward et 
al., 1998; Waschek et al., 1998; Basille et al., 2000; Jaworski and Proctor, 2000) 
including mouse OE (Hegg et al., 2003).   
 PAC1 is a 7-transmembrane G-protein coupled receptor that has several 
splice variants (Spengler et al., 1993).  The different splice variants of PAC1 
have been demonstrated to differentially couple to different signal transduction 
pathways.  The long form, containing a hop cassette, can activate both adenylyl 
cyclase (AC) and phospholipase C (PLC) transduction pathways, while the short 
variant, lacking the hop cassette, only activates the AC transduction pathway (Lu 
et al., 1998; Waschek, 2002).  AC activation increases levels of cyclic adenosine 
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monophosphate (cAMP) which leads to protein kinase A (PKA) activity.  PKA can 
translocate into the nucleus and phosphorylate cAMP response element binding 
protein (CREB), a transcriptional activator.  In comparison, the PLC pathway 
breaks down phosphatidylinositol into inositol triphosphate (IP3) and 
diacyglycerol (DAG), which function as second messengers.  IP3 releases Ca+2 
from internal stores, and DAG activates protein kinase C (PKC), both of which 
can act on downstream messengers that lead to transcription.  PACAP has the 
ability, through coupling of these signal transduction pathways, to regulate 
multiple transcription factors that control gene expression (Holighaus et al., 
2011). 
 
PACAP influences neuronal proliferation and differentiation 
PACAP is involved in many aspects of neurogenesis, including neuronal 
proliferation.  PACAP can affect proliferation in either a stimulatory or an 
inhibitory manner.  In vitro studies have shown stimulatory effects of PACAP on 
proliferation, with increased bromodeoxyuridine (BrdU) positive cells in primordial 
germ cells (Pesce et al., 1996) as well as in embryonic day 14.5 mouse neural 
progenitor cells (Nishimoto et al., 2007).  PACAP can also regulate adult 
neurogenesis.  For example, PACAP induces proliferation in cultures of neural 
stem cells isolated from the lateral ventricle wall in adult mice (Mercer et al., 
2004) and in rat granule cells (Vaudry et al., 1999).  In vivo studies have also 
demonstrated a stimulatory effect of PACAP on cell division.  
Intracerebroventricular infusion of PACAP increases the number of BrdU positive 
  
4 
cells in both the hippocampus and subventricular zone in mice (Mercer et al., 
2004; Ohta et al., 2006).  Additionally, local administration of PACAP increases 
cerebellar cortex volume (Vaudry et al., 1999).  Combined, these studies imply 
that PACAP functions to increase neuronal proliferation during development as 
well as later stages of life. 
In contrast to the demonstrated stimulatory effects of PACAP, many 
studies have also shown an inhibitory effect of PACAP on proliferation.  In vitro, 
PACAP inhibits 3Hthymidine incorporation in embryonic day 13.5 cortical 
precursor cells (Lu and Dicicco-Bloom, 1997) and decreases BrdU incorporation 
in cerebellar granule cells (Carey et al., 2002; Contestabile et al., 2005).  It is 
also suggested that PACAP inhibits proliferation in vivo, as an overexpression of 
the PACAP receptor PAC1 leads to early exit of cell cycle in the mouse retina 
(Lang et al., 2010). 
The differential control of proliferation by PACAP could be due to origin 
and age of the cells and differences in the systems in question.  It has been 
implied that the difference in stimulation and inhibition of PACAP on proliferation 
is due to differential expression of PAC1 receptor splice–variants (Lu et al., 
1998).  However, this regulation by PACAP can be influenced by other growth 
factors as well.  In cultured cerebellar granule cell precursors, sonic hedgehog 
(Shh) alone greatly increased thymidine incorporation whereas PACAP alone 
only yielded a moderate increase.  Yet when cultures contained both PACAP and 
Shh, PACAP inhibited Shh-induced proliferation (Nicot et al., 2002).  The 
presence of basic fibroblast growth factor in embryonic mouse hindbrain cultures 
  
5 
switches the stimulatory effect of PACAP on proliferation to an inhibitory action 
(Lelievre et al., 2002).  The importance of this switch by PACAP could indicate a 
mechanism for how differential expression of growth factors during development 
can achieve balance that results in the correct number and type of cells within a 
system. 
PACAP-induced proliferation could simply lead to increased numbers of 
neurons, but PACAP can also function to promote neuronal differentiation.  In 
vitro studies with PC12 cells have demonstrated that addition of PACAP to 
cultures induces neurite outgrowth (Sakai et al., 2001; Grumolato et al., 2003).  
PACAP also increases the number of neurite bearing cells, neurite growth and 
branching, and expression of neuronal proteins in cultures of many different cell 
types (Cazillis et al., 2004; Heraud et al., 2004; Tzeng et al., 2004; McIlvain et al., 
2006; Ohta et al., 2006; Monaghan et al., 2008).  For example, culturing 
mesencephalic dopaminergic neurons from embryonic rat in the presence of 
PACAP leads to an increase in tyrosine hydroxylase immunoreactive neurons 
(Takei et al., 1998).  Cultured cortical precursor cells have increased number of 
cells bearing neurites and expression of trkB receptors when exposed to PACAP 
(Lu and Dicicco-Bloom, 1997).  These studies suggest that PACAP promotes 
neuronal differentiation in vitro, and imply that PACAP serves more than just a 






PACAP influences survival and apoptosis 
 In addition to effects on neuronal proliferation and differentiation, PACAP 
has prosurvival and anti-apoptotic effects in many mammalian systems.  In vitro 
studies have shown that incubation with PACAP decreases the number of 
apoptotic and caspase-3 (a pro-apoptotic protein) positive PC12 cells (Dejda et 
al., 2010), chicken cochlear cells (Racz et al., 2010) and primary adult mouse OE 
(Han and Lucero, 2005).  PACAP is also protective against induced toxicity.  
PACAP inhibits apoptosis and caspase-3 activation induced by rotenone, a 
mitochondrial complex 1 inhibitor implicated in Parkinson’s disease, in PC12 cells 
(Wang et al., 2005).  In addition, PACAP protects dopaminergic cultures by 
preventing cell death from both 1-methyl-4-phenylpyridinium ion (MPP+) and 6- 
hydroxydopamine (6-OHDA) induced toxicity (Takei et al., 1998; Chung et al., 
2005; Deguil et al., 2007).  This further supports the idea of a protective role of 
PACAP in Parkinson’s disease and could provide a therapeutic target.   
  The protective role of PACAP has been extensively studied in cerebellar 
granule cells as well.  In culture, PACAP inhibits C2-ceramide-induced activation 
of caspase-3 (Vaudry et al., 2003) and cytochrome c release (Falluel-Morel et al., 
2004).  In cerebellar granule cell culture, PACAP also inhibits activation of 
caspase-3 induced by hydrogen peroxide (Vaudry et al., 2002a) and ethanol 
toxicity (Vaudry et al., 2002b; Mei et al., 2004).  Collectively, these studies 
suggest that PACAP inhibits mitochondrial apoptotic pathways to promote cell 
survival in vitro.  PACAP can also influence ion channel activity. Increased 
activity of voltage gated calcium channels and reduced delayed outward rectifier 
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K+ current by PACAP is suggested to play a role in protection (Tabuchi et al., 
2001; Mei et al., 2004; Han and Lucero, 2005). 
 The protective and anti-apoptotic effects of PACAP are also seen in vivo.  
PACAP knock-out (KO) mice have altered cerebellar development with reduced 
thickness of cell layers and increased caspase-3 activation (Allais et al., 2007).  
Intracerebral administration of PACAP into adult rats greatly reduces 
hippocampal neuronal cell death after ischemia (Stetler et al., 2010).  Ischemia 
has also been shown to induce greater damage in PACAP KO mice, which was 
ameliorated with injection of PACAP (Ohtaki et al., 2006). PACAP is also 
protective against retinal degeneration induced by both monosodium glutamate 
(Racz et al., 2006) and carotid occlusion (Atlasz et al., 2007).  In a model of 
mechanical spinal injury, PACAP application decreased the number of apoptotic 
cells (Chen and Tzeng, 2005).  This implies that PACAP exerts trophic effects in 
the peripheral as well as central nervous system.  PACAP could thus be a new 
tool for therapies for degeneration and injury of the nervous system. 
 
Phenotype of PACAP Knock-Out mice 
 PACAP KO mice exhibit a complex phenotype, affecting many organ 
systems, which changes over the course of their lifespan.  In addition to 
increased susceptibility to early postnatal death (Gray et al., 2001; Hashimoto et 
al., 2001), neonatal PACAP KO mice have accumulations of fat in the liver, heart, 
and skeletal muscle (Gray et al., 2001).  Additionally, neonatal PACAP KO mice 
experience reduced ventilation during baseline breathing and diminished 
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respiratory responses to hypoxia, which could lead to apnea (Cummings et al., 
2004), both of which could contribute to the increased risk for postnatal death.  
Furthermore, PACAP KO mice express decreased levels of both dopamine and 
norepinephrine in brown adipose tissue, leading to insufficient heat production 
and hypothermia; rearing the litters at an increased temperature increases post-
natal survival rates (Gray et al., 2002).  Finally, neonatal PACAP KO mice exhibit 
increased kidney damage after hypoxia (Horvath et al., 2010) and have altered 
cerebellar development (Allais et al., 2007). 
 The phenotype of PACAP KO mice that survive to adulthood is similarly 
complex.  Adult female PACAP KO mice are prone to decreased embryo 
implantation and significantly fewer gave birth after mating compared to WT 
mice, although other aspects of fertility are normal (Isaac and Sherwood, 2008). 
Mature PACAP KO mice are hypersensitive to inflammation (Elekes et al., 2011) 
and hypoxia (Szakaly et al., 2011), and demonstrate reduced food intake (Nakata 
et al., 2004; Tomimoto et al., 2008) as well as increased insulin sensitivity and 
smaller body mass (Tomimoto et al., 2008).  Altered light-induced phase shifts 
have also been observed in PACAP KO mice (Kawaguchi et al., 2003; Colwell et 
al., 2004; Kawaguchi et al., 2010). In addition to physiological alterations, PACAP 
KO mice demonstrate altered behavior.  PACAP KO mice exhibit increased 
locomotor activity and exploratory behavior, and show signs of being less fearful 
and anxious ( Hashimoto et al., 2001; Girard et al., 2006).  Increased jumping 
behavior was also observed in PACAP KO mice (Hashimoto et al., 2001); this 
abnormal behavior could be suppressed by increasing serotonin levels (Shintani 
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et al., 2006).  PACAP KO mice display decreased nocifensive behavior, 
suggesting altered pain transmission (Sandor et al., 2010).  The variety and 
distribution of differences between PACAP KO and WT mice suggest the many 
functions PACAP may have, and further indicate that PACAP may play a variety 
of roles over the course of development and across organ systems.  
 
PACAP in the Olfactory System 
Anatomy, function, and regeneration of the olfactory  
system 
 The OE is a pseudostratified neuroepithelium containing the odorant 
detecting olfactory sensory neurons (OSNs), which mediate the sense of smell.  
In mammals, the OE is located in the posterior nasal cavity and is constantly 
exposed to airborne toxins and xenobiotics.  The OSN soma is located in the 
middle third of the OE and extends a dendrite to the apical surface that ends in 
odorant receptor-containing cilia that are exposed to the mucosa.  The OSN axon 
extends to and passes through the basal edge of the OE, the basement 
membrane, and joins other axons to form a nerve bundle that projects to the 
olfactory bulb, within the central nervous system, to form the primary synapse.  
Sustentacular cells are glial-like support cells that form the most apical cell layer 
in the OE, just above the OSNs, and extend processes basally to the basement 
membrane.  Below the OSN somas are immature OSNs.  The most basal layer 
of the OE, located above the basement membrane, consists of two types of basal 
stem cells (BC), the horizontal basal cells (HBCs) and globose basal cells 
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(GBCs). GBCs are considered to be more pluripotent than HBCs (for review see 
Murdoch and Roskams, 2007).  The basement membrane separates the 
neuroepithelium from the glands, nerve bundles, and blood vessels of the 
olfactory submucosa. 
 The OE has the unique ability to regenerate after cell death (for review 
see Schwob, 2002).  Damaging exposure from the environment causes OSNs 
and sustentacular cells to become apoptotic.  The damaged cells then release 
ATP (and possibly other signaling molecules) to stimulate proliferation of BCs 
(Hegg and Lucero, 2006; Jia et al., 2009).  One of the daughter cells of BC 
proliferation will replace the dying OSN by differentiating into an immature OSN 
that matures into a functioning OSN.  GAP43, a cytoskeletal component of 
extending growth cones, is expressed in immature OSNs.  Once immature OSN 
axons reach their targets on the olfactory bulb, GAP43 expression is down-
regulated and increased olfactory marker protein (OMP) expression signals 
maturity.  This tightly regulated turnover and replacement of damaged cells 
keeps the number of OSNs within the OE constant.  Even when damage is 
widespread from lesion or insult, the OE still has the capacity to regenerate 
neurons that mature and functionally integrate into the OE.  Progenitors within 
the BC population are capable of generating both neurons and sustentacular 
cells (Leung et al., 2007).  This remarkable regenerative capacity of the OE is 
retained throughout adulthood.  Understanding adult neurogenesis in the OE 
could lead to the discovery of important therapeutic targets against neuronal 
degeneration and injury. 
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PACAP in OSN turnover 
 Both PACAP and its receptor (PAC1) are present in adult and developing 
olfactory bulb (Jaworski and Proctor, 2000) and OE (Hansel et al., 2001; Hegg et 
al., 2003). It has been suggested that PACAP may influence OSN turnover in the 
OE.  Differential expression of PACAP is seen between neonatal and adult mice 
and between adult mouse and rat in the OE.  In neonatal mice, 
immunofluorescence demonstrated PACAP localization in the olfactory 
ensheathing cells within the submucosa.  In contrast, PACAP was present in all 
cells of the adult mouse OE. The highest concentration of PACAP labeling, 
however, occurs in the BC layer (Hegg et al., 2003).  In adult rat OE, PACAP 
protein and mRNA were present in all but sustentacular cells (Hansel et al., 
2001; Hegg et al., 2003).  In adult rats, the PAC1 receptor was demonstrated to 
reside on BCs and immature OSNs (Hansel et al., 2001).  The different 
expression patterns for PACAP between neonates and adults imply that the 
function of PACAP could change depending on age. 
In vitro studies have documented the effects of PACAP on proliferation, 
maturation, and survival of cells from the OE.  Hansel et al. (2001) showed that 
exogenous PACAP increases proliferation in neonatal rat primary OE cultures 
and increases the number of neurons.  These data suggest PACAP may affect 
both proliferation and OSN survival.  OSN activity is involved in survival of 
neurons in OE and olfactory bulb (Petreanu and Alvarez-Buylla, 2002; Watt et al., 
2004).  Indeed, PACAP increases OSN excitability and maturation of olfactory 
placodal cell lines by increasing Na+ currents and OMP expression (Illing et al., 
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2002).  In mouse OE primary cultures or slices, PACAP increases intracellular 
Ca+2, most likely through release from intracellular stores (Hegg et al., 2003), 
which may be important for turning on maturation or survival programs by 
regulating transcription through downstream effectors.  In cerebellar neurons, 
PACAP is anti-apoptotic by decreasing K+ currents (Mei et al., 2004).  Similarly, 
PACAP inhibition of K+ channel expression in mouse OSNs (Han and Lucero, 
2006) correlates with decreases in caspase-3 activation and increased survival 
(Han and Lucero, 2005).  PACAP also reduces TNFα-induced apoptosis in 
mouse neonatal OE slices and olfactory cell lines (Kanekar et al., 2010).  
Collectively, these studies suggest that PACAP could be involved in OE 
development and maintenance in vivo. In mice lacking all amidated petides 
including PACAP, there is a reduction in OE height (Hansel et al., 2001).  
However, the direct role of PACAP in the OE has not yet been examined in vivo. 
 PACAP may also be indirectly involved in OE survival and regeneration by 
modulating inflammatory responses.  During OSN apoptosis induced by 
bulbectomy, or axon target removal, levels of the chemokine MIP-1α increase 
and macrophages are recruited to the OE (Getchell et al., 2002a; Getchell et al., 
2002b; Kwong et al., 2004).  Disruption of the inflammatory response or depletion 
of macrophages leads to increased apoptosis and decreased neurogenesis in 
the OE after bulbectomy (Getchell et al., 2006; Borders et al., 2007).  Together, 
these data imply that inflammatory responses are important for the regeneration 
of the OE.  PACAP is involved in such inflammatory responses (for review see 
Leceta et al., 2000; Delgado et al., 2003).  PACAP can activate K+ currents 
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(Ichinose et al., 1998) and inhibit chemokine gene expression (Delgado et al., 
2002) in cultured microglia.  In vivo studies show that intranasal administration of 
a PAC1 receptor agonist, maxadilian, had anti-inflammatory effects in an 
ovalbumin-induced asthma model (Lauenstein et al., 2011).  Axon regeneration 
after facial nerve injury was delayed in PACAP KO mice due to increased 
expression of pro-inflammatory cytokines (Armstrong et al., 2008).  Again, 
PACAP may play a modulatory role in the regeneration of the OE, as OE 
regeneration is dependent on an inflammatory response that can be modulated 
by PACAP. 
  
 Outline of the Dissertation 
 This dissertation describes various roles of PACAP in vivo, during the 
development, adult maintenance, and injury-induced regeneration of the OE. In 
Chapter 1, we have introduced the olfactory epithelium as a model system for 
adult neurogenesis and have discussed current knowledge of the roles of 
PACAP. In this dissertation, we utilize PACAP KO mice to answer three 
questions: 1) What is the role of PACAP in OE development?  2) What is the role 
of PACAP in adult OE maintenance?  3) What role does PACAP play in adult 
regeneration of OE after injury? 
 In Chapter 2, we inject mice with BrdU to measure proliferation and used 
immunofluorescence staining to evaluate OSN numbers.  We demonstrated an 
age-dependent function of PACAP.  In neonatal mice postnatal day 3 (P3), when 
the OE is still developing, loss of PACAP leads to decreased proliferation and 
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immature OSNs compared to wild-type (WT) littermates.  At P7, when the OE is 
switching to a mature state there are no differences in proliferation or immature 
OSNs between PACAP KO and WT mice.  However, in adult OE, a lack of 
PACAP causes increased proliferation in the PACAP KO compared to WT.  
Although proliferation is increased, the OE height and total cell numbers are 
reduced in PACAP KO.  However, there are no differences in the numbers of 
mature OSNs between PACAP KO and WT mice at any age examined.  In 
support of PACAP KO mice having normal OSNs numbers, a simple olfactory 
behavioral test demonstrated that adult PACAP KO mice have normal olfactory 
function in detecting food odors compared to WT mice.  Surprisingly, these data 
suggest that PACAP is not required for BC proliferation or OSN maturation but 
PACAP does appear to be required for survival of all cell types in the OE. 
 In Chapter 3, we investigate PACAP in OE regeneration by inducing mass 
OE degeneration with an olfactory toxicant named methimazol.  Western blot and 
quantitative reverse transcriptase-PCR (qRT-PCR) were used to investigate 
different inflammatory markers before and after insult.  A simple olfactory 
behavioral paradigm was employed to monitor anosmia onset and recovery after 
insult.  PACAP KO mice displayed both earlier onset of anosmia and speedier 
recovery after insult.  Faster recovery could be due to the increase in proliferation 
seen in adult PACAP KO mice.  These results suggest that PACAP fills a 
protective role in delaying OSN death after injury. 
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 Chapter 4 is a discussion and summary of the data.  The significance and 
limitations of this data are examined.  Also the implications for PACAP in 
neurogenesis and future directions are addressed. 
 The Appendix includes a manuscript describing that the prenyl binding 
protein PrBP/δ enables trafficking of Golf to olfactory cilia.  This work is in 
collaboration with Dr. Baehr (University of Utah, Salt Lake City). 
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CHARACTERIZATION OF THE OLFACTORY  




 Pituitary adenylate cyclase-activating polypeptide (PACAP) impacts many 
neurogenic processes, including proliferation, maturation, and survival.  The 
olfactory epithelium (OE) has the remarkable capacity to regenerate olfactory 
sensory neurons (OSNs), even in adult mammals, and is therefore an excellent 
model to study neurogenesis.  In vitro studies have shown that incubation with 
PACAP increases proliferation of basal cells (BCs) and OSN numbers, or 
decreases OSN apoptosis in both neonatal and adult OE cultures. However, the 
effect of PACAP on the OE has not been examined in vivo.  To investigate the 
role of PACAP in proliferation and OSN survival in vivo, we compared wild-type 
(WT) and PACAP knock-out (KO) OE in neonatal and adult mice.  To examine 
proliferation, mice were injected with BrdU 2 hr before sacrifice at various 
developmental time points.  The OE was cryo-sectioned and immunostained with 
antibodies against BrdU.  The total number of cells, as well as number of 
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immature and mature OSNs, was measured.  Postnatal day 3 (P3) PACAP KO 
mice exhibited a significant decrease in proliferation and immature OSN 
immunolabel compared to WT mice.  However, there were no differences in the 
numbers of total cells or mature OSNs between PACAP KO and WT P3 mice.  
Interestingly, PACAP KO mice did not differ from WT mice at P7.  The OE from 
adult PACAP KO mice, however, was compromised by a significant decrease in 
total number of cells and OE height.  Measurements of layer height in the OE 
suggest the highest levels of cell death are in immature OSNs.  However, 
PACAP KO mice have normal amounts of OSNs and demonstrate normal food 
detection behavior.  Surprisingly, adult PACAP KO mice show significantly 
increased proliferation of BCs compared to WT mice, suggesting PACAP is not 
required for adult proliferation.  We conclude that PACAP is involved in early OE 
proliferation and in normal maintenance and survival of adult, but not neonatal, 
OE in vivo. 
 
Introduction 
PACAP is a pleiotropic peptide involved in many neurogenic processes 
including proliferation, maturation, and survival (for review see Waschek, 2002).  
PACAP-induced proliferation has been observed in multiple adult and embryonic 
mouse brain regions.  In vitro studies have shown that proliferation increases 
with incubation of PACAP in cultures of neural progenitor cells from embryonic 
(Nishimoto et al., 2007), neonatal (Scharf et al., 2008), and adult mice (Mercer et 
al., 2004).  PACAP also increases proliferation in embryonic neural precursor 
  
26 
cultures from hindbrain (Lelievre et al., 2002) and forebrain (Ohta et al., 2006).  
In cerebellar granule cells, incubation with PACAP causes a rise in 3Hthymidine 
incorporation, indicating increased DNA synthesis (Vaudry et al., 1999; Nicot et 
al., 2002).  PACAP also increases proliferation in vivo.  Intracerebellar 
administration of PACAP significantly increased the volume of neonatal rat 
cerebellar cortex (Vaudry et al., 1999).  In addition, intracerebroventricular 
infusion of PACAP increases proliferation in the hippocampus and ventricular 
zones in adult mice (Mercer et al., 2004; Ohta et al., 2006).  Taken together, 
these studies imply that PACAP functions to promote neuronal proliferation 
during both development and later stages of life. 
However, PACAP has also been shown to inhibit proliferation.  On 
cultured cortical precursor cells, PACAP inhibited 3Hthymidine incorporation (Lu 
and Dicicco-Bloom, 1997).  In contrast to studies mentioned above, Contestabile 
et al. (2005) showed that PACAP decreased bromodeoxyuridine (BrdU) uptake in 
cerebellar granule cells.  In this case, however, decreased proliferation could be 
due to differences in culture media used, as the presence of other growth factors 
can modulate the effects of PACAP on proliferation (Lelievre et al., 2002; Nicot et 
al., 2002).  In vivo studies have also shown that PACAP inhibits proliferation.  
Administration of PACAP led to decreased BrdU incorporation in the cortex of P8 
rat pups (Suh et al., 2001).  In addition, overexpression of PACAP’s receptor 
PAC1 leads to early exit of retinal proliferation and decline in visual function 
(Lang et al., 2010).  Collectively, the above studies indicate that PACAP can 
cause a reduction in proliferation.  Further, these studies show that the effects of 
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PACAP can be influenced by the environment to either induce or inhibit 
proliferation.   
In addition to inducing or inhibiting proliferation, PACAP can modulate 
neuronal differentiation.  In vitro studies with PC12 cells have demonstrated that 
addition of PACAP to culture induces neurite outgrowth (Sakai et al., 2001; 
Grumolato et al., 2003).  In addition, in cultures of a human neuroblast SH-SY5Y 
cell line, PACAP increases the number of neurite bearing cells (Monaghan et al., 
2008), neurite growth and branching, as well as neuronal protein levels (Heraud 
et al., 2004).  PACAP-induced increases in neurite growth and branching have 
also been shown in cultures of size-sieved stem cells, derived from human bone 
marrow (Tzeng et al., 2004), mouse embryonic stem cells (Cazillis et al., 2004), 
and in F11 neuroblastoma/dorsal root ganglion hybrid cells (McIlvain et al., 
2006).  An increase in expression of neuronal proteins is also seen with 
incubation of PACAP in stem cell cultures (Cazillis et al., 2004; Tzeng et al., 
2004).  Furthermore, increases in the neuronal marker tyrosine hydroxylase are 
seen in embryonic rat dopaminergic cells incubated with PACAP (Takei et al., 
1998).  In addition, cortical precursor cells have an increase in the number of 
neurite bearing cells and expression of trkB receptors when exposed to PACAP 
(Lu and Dicicco-Bloom, 1997).  The increase in neurite bearing cells plus the 
addition of increased neuronal markers suggest that PACAP promotes neuronal 
differentiation both in vitro and in vivo.  Collectively, these studies suggest that 
PACAP can modulate multiple aspects of developmental and adult neurogenesis. 
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The olfactory system provides an excellent model for the study of 
neurogenesis.  The OE is a pseudostratified neuroepithelium containing the 
odorant detecting olfactory sensory neurons (OSNs) which mediate our sense of 
smell. When damaged, the OE regenerates neurons that mature and functionally 
integrate into the OE. This remarkable regenerative capacity of the OE is 
retained throughout adulthood due to a layer of basal stem cells (BC) residing 
above a basement membrane that separates the neuroepithelium from the 
glands, nerve bundles, and blood vessels of the olfactory submucosa.  
Progenitors within the BC population are capable of generating both neurons and 
sustentacular cells (Leung et al., 2007). Immature neurons are situated above 
the basal cell layer and express GAP43, a marker of extending growth cones. 
Once immature OSN axons reach their targets in the olfactory bulb, GAP43 
expression is down-regulated and the increased olfactory marker protein (OMP) 
expression signals maturity.  The OMP positive OSNs are found apical to the 
GAP43 immature neurons and extend dendrites to the apical surface of the OE. 
Mature OSNs are found in the middle to upper layer of the OE and somas of 
sustentacular cells, the glial-like support cells form the most apical OE layer.  
Both PACAP and its receptor (PAC1) are detected in adult and developing 
olfactory bulb (Jaworski and Proctor, 2000) and OE (Hansel et al., 2001; Hegg et 
al., 2003), therefore it has been suggested that PACAP may influence OSN 
turnover in the OE. 
In vitro studies have documented the effects of PACAP on proliferation, 
maturation, and survival of cells from the OE. Hansel et al. (2001) showed that 
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addition of PACAP increases proliferation in neonatal rat primary OE cultures. In 
mouse OE primary cultures or slices, PACAP increases intracellular Ca+2 (Hegg 
et al., 2003), which may be important for turning on downstream maturation or 
survival programs.  Since OSN survival can be dependent on activity levels (Watt 
et al., 2004), PACAP may affect excitability of the cell.  Indeed, PACAP increases 
OSN excitability and maturation of olfactory placodal cell lines by increasing Na+ 
currents and levels of OMP (Illing et al., 2002). In cerebellar neurons, PACAP 
has anti-apoptotic effects associated with decreasing K+ currents (Mei et al., 
2004). Similarly, PACAP inhibition of K+ channel expression in OSNs (Han and 
Lucero, 2006) correlates with decreases in caspase activation and increased 
survival (Han and Lucero, 2005). PACAP also reduces TNFα-induced apoptosis 
in neonatal OE slices and olfactory cell lines (Kanekar et al., 2010). PACAP 
could enhance maturation and survival by increasing the excitability of OSNs in 
conjunction with activity promoted survival mechanisms. 
 In mice lacking all amidated petides, including PACAP, there is a 
reduction in OE height (Hansel et al., 2001), suggesting a role for PACAP within 
the OE in vivo.  However, the direct role of PACAP in the OE has not yet been 
examined.  Using PACAP KO mice, we examined how the absence of PACAP 











 All animal procedures were approved by the University of Utah 
Institutional Animal Care and Use Committee, and all applicable guidelines from 
the National Institutes of Health (NIH) Guide for Care and Use of Laboratory 
Animals were followed.  C57BL/6 PACAP heterozygote mice were obtained from 
Dr. N. Sherwood (Univ. of Victoria) for breeding (Gray et al., 2001).  
Heterozygote breeding pairs and pups were maintained at 30°C to prevent 
hypothermia in the PACAP KO mice (Gray et al., 2002).  Once weaned at 3-4 
weeks, littermates were group housed at 21°C in same sex cages on 12 hr 
light/dark cycle with food and water ad libitum.  Tail biopsies were genotyped by 
Transnetyx (Cordova, TN).  For olfactory behavior studies, 27 WT and 29 
PACAP KO mice were used. For immunofluorescence studies, we analyzed 9 
WT and 10 PACAP KO mice, including 3 C57BL/6 PACAP KO heads obtained 
from Dr. J. Washek (University of California, Los Angeles).   
 
Tissue collection 
 Wild-type and PACAP KO mice were injected with BrdU (BD Biosciences, 
San Jose, CA) dissolved in 0.1 M phosphate buffered saline (PBS) 2 hr before 
sacrifice (P3, P7 mice: 50 mg/kg BrdU; P64 mice: 1 mg/mL BrdU).  Wild-type and 
PACAP KO mice were perfusion fixed with 4% Formal-Fixx (FF) (Thermo 
Scientific, Waltham, MA) and the skin and lower jaw were removed from the 
head.  The heads were postfixed in 4% FF at 4°C overnight.  Adult heads were 
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rinsed in PBS and decalcified for 2 hr (Rapid decalcifier, Apex Engineering 
Products Corp., Plainfield, IL).  The heads were rinsed twice in PBS and serially 
cryo-protected in 15% and 30% sucrose at 4°C overnight.  Heads were 
embedded in Tissue-Tek optimal cutting temperature (OCT) (Fisher Scientific, 
Pittsburgh, PA) and frozen in an ethanol/dry ice bath.  Frozen coronal sections 
(10 µm thick) of OE were cut on a cryostat and serially collected on 
Superfrost/Plus slides (Fisher Scientific, Pittsburgh, PA). 
 
Hematoxylin and Eosin staining 
 A subset of frozen sections was stained using Harris Hematoxylin (Sigma, 
St. Louis, MO) and counterstained in Eosin (Sigma). Briefly, slides were hydrated 
in PBS, soaked 3 min in hematoxylin, decolorized 10 sec in acid alcohol (0.025% 
HCl in 70% EtOH), rinsed in H2O, blued for 10 sec in 0.1% lithium carbonate, 
rinsed in running tap water 5 min, counterstained in eosin for 20 sec, dehydrated 
twice each in 95% and 100% EtOH, cleared 2x5 min in xylene and mounted with 
xylene-based mounting medium DPX (BDH Laboratory Supplies, Poole, 
England).  Slides were imaged on a Nanozoomer Digital Pathology system 2.0 
(Hamamatsu, Hamamatsu City, Japan). 
 
Immunofluorescence 
 Frozen OE sections were dried and then rehydrated with wash buffer 
(0.1M PBS, 0.2% Triton-X, 1% BSA) for 30 min.  For BrdU labeling, slides were 
then incubated in 2M HCl for 1 hr at 37°C to denature DNA and then neutralized 
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with Borate buffer (pH 8) for 10 min.  Slides were washed and blocked with 5% 
donkey serum for 30 min.  Slides were washed and incubated in primary 
antibodies.  The mouse anti-BrdU primary antibody (6 µg/ml, Roche, 
Indianapolis, IN) used for measuring proliferation, was incubated for 1 hr at room 
temperature.  Goat anti-olfactory marker protein (OMP) (1:2000, a gift from Dr. F. 
Margolis) used for labeling mature OSNs, and rabbit anti-GAP43 (1:10,000, 
Chemicon International, Temecula, CA) for labeling immature OSNs, were 
incubated at 4°C overnight.  Slides were washed and the appropriate donkey-
anti-mouse, rabbit or goat secondary antibody conjugated to either fluorescein 
isothiocyanate (FITC) or tetramethyl rhodamine isothiocyanate (TRITC) (1:100, 
Jackson Immunoresearch, West Grove, PA) was applied for 30 min in the dark.  
Sytox Green (1:25,000, Molecular Probes, Carlsbad, CA) was used to mark cell 
nuclei to obtain total cell counts and was applied for 15 min in the dark.  Slides 
were washed and cover slipped with Vectashield Mounting medium for 
Fluorescence (Vector, Burlingame, CA). 
 
Microscopy and analysis 
 All image collection and analysis was conducted blind to genotype. Slides 
were selected to match the same level of endoturbinate 2 from each animal. 
Images of 6 specific regions (Fig. 2.1A) of OE on each section were captured 
using a Zeiss LSM 510 confocal microscope using a Zeiss water immersion 20x 
objective and processed using ImageJ software.  The height of the OE was 
measured 3 times along a 150 µm length of OE in each image.  The 3 height 
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measurements were averaged and recorded as the height of the OE for that 
image (Fig. 2.1B).  The heights for a specific region were averaged across 
animals of the same genotype (Fig. 2.1C).  In addition, 3 height measurements 
were made and averaged for each of 3 layers in the OE.  We measured the 
height of the BCs and immature OSNs as a layer, OMP-labeled OSNs were 
another layer, and sustentacular cells make the final layer.  For 
immunofluorescence analysis of OMP, BrdU, and Sytox Green staining, the 
background was subtracted and the numbers of positively stained cells were 
counted in a 150 µm length of OE.  For GAP43 staining, the percentage of 
labeled pixels in an area with 150 µm length of OE was determined. To adjust for 
OE height differences, we divided the PACAP KO OE height by the WT height to 
obtain a correction factor.  The value obtained as the correction factor was 
multiplied by the percent of GAP43 label in the PACAP KO and calculated 
averages for each age group were obtained.  We analyzed a minimum of 4 
images for each labeling condition from each animal.  Statistical significance 
between WT and PACAP KO mice for the regions measured was determined 
using Student’s t-tests with P values < 0.05.  Data is reported mean ± sem. 
 
Food retrieval task 
 All behavioral tests were performed blind to genotype. To test olfactory 
function, adult mice were individually trained to locate a piece of chocolate 
covered malt ball (Whoppers™, Hershey, PA) buried in clean bedding.  A mouse 
with normal olfactory function will be able to smell or detect and then locate the 
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malt ball, while deficiencies in function will result in a longer latency to locate the 
malt ball.  Each mouse was acclimated to the testing room in a clean cage for 30 
min before starting the task.  Mice were placed in a new clean cage with 3 cm of 
clean corncob bedding and allowed to explore for 5 min.  A piece of malt ball was 
buried in the bedding and the mouse was allowed to explore for another 5 min.  
The latency to find the malt ball was recorded.  Mice performed 1 trial a day and 
were considered trained when they found the malt ball in less than 60 sec for 3 
consecutive trials.  Statistical significance between WT and PACAP KO mice was 
determined using Student’s t-tests with P values < 0.05.  Data is reported as 
mean ± sem. 
 
Results 
PAPCAP and OE thickness 
 Previous studies using Brindled mice indicated that amidated peptides 
such as PACAP are required for normal development of mouse OE (Hansel et 
al., 2001).  This study addressed all amidated peptides, of which there are 
several in the OE.  We decided to investigate the specific role of PACAP alone in 
OE development in vivo using the PACAP KO mouse (Gray et al., 2001). We 
examined the OE height (thickness) in WT and PACAP KO mice at ages P3, P7, 
and P64.  We found that the OE thickness did not differ between PACAP KO and 
WT at P3 (76.5±1.9 vs 79.5±2.8 µm, p=0.24) or P7 (91.3±2.4 vs 88.3±2.2 µm, 
p=0.39).  However, the P64 PACAP KO mice had a significantly thinner OE than 
WT mice (57.1±1.5 vs 77.6±2.7 µm, p=0.004) (Fig. 2.1C).  The difference in 
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effect of PACAP between neonatal and adult mice could be due to the differential 
expression of PACAP at these ages.  In neonatal mice, PACAP is located in the 
OSN nerve bundle within the submucosa, whereas in adults PACAP is found 
throughout the OE but most concentrated in BCs (Hegg et al., 2003).  To 
examine which cells may be compromised in P64 PACAP KO mice OE, we 
measured the height of 3 different layers in the OE.  We measured the height of 
BCs and immature OSNs as one layer, OMP-labeled OSNs as the second layer, 
and the apical sustentacular cells for the final layer.  The PACAP KO mice were 
significantly thinner in all 3 layers compared to WT, the most significant 
difference being in the basal layer (10.7±0.6 vs 20.6±1.5 µm, p=0.00001).  The 
sustentacular cell layer was the second most affected (14.8±0.5 vs 19±1.1 µm, 
p=0.008) and the OSN layer was the least affected (27.7±1.2 vs 34.8±2.3 µm, 
p=0.014).  These data suggest that PACAP is not required for the development 
of OE since neonatal PACAP KO mice have normal epithelial thickness.  
However, the decrease in OE thickness in P64 PACAP KO mice suggest PACAP 
is involved in maintaining all cell types of the juvenile/adult OE. 
 
The effects of PACAP on OE proliferation 
 PACAP is found in proliferative regions of the brain and shown to increase 
proliferation when added to primary cultures of hippocampus (Mercer et al., 
2004; Ohta et al., 2006), cerebellum (Vaudry et al., 1999), and OE (Hansel et al., 
2001).  The thinner OE we observed in P64 PACAP KO mice suggests that lack 
of PACAP leads to a decrease in proliferation, an increase in cell death, or some 
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combination of decreased proliferation and increased apoptosis/necrosis.  To test 
for a change in proliferation in vivo, we injected the cell proliferation marker BrdU 
into WT and PACAP KO mice 2 hr before sacrifice at ages P3, P7, and P64.  
Figure 2.2A shows immunolabeling of BrdU.  At age P3, the PACAP KO mice 
had significantly fewer BrdU-labeled cells than the WT (13.3±1.1 vs 20.7±1.4 
cells/150 µm, p=0.026; Fig 2.2B).  However at P7, there were no differences in 
the number of BrdU positive cells (17±1.3 vs 17.5±1 cells/150 µm, p=0.781; Fig 
2.2B).  At P7, the OE is transitioning into a mature state and could utilize different 
factors for regulation of proliferation between developmental and mature states.  
Surprisingly, at age P64, the PACAP KO mice had significantly more BrdU 
positive cells than WT mice (5.5±1 vs 1.7±0.2 cells/150 µm, p=0.01; Fig 2.2B).  
This is in contrast to the decreased OE thickness we see and implies that there 
may be increased cell death and turnover in the PACAP KO OE or that cellular 
size may be reduced.  These results suggest that PACAP is not required for 
proliferation in the OE and that the absence of PACAP leads to decreased 
proliferation (S phase entry) in early neonatal stages but at later stages, 
proliferation in PACAP KO mice increases and actually surpasses that of the WT 
mice by P64. 
 
PACAP and total cell number in the OE 
 The P3 KO mice have decreased BrdU labeling suggesting reduced 
proliferation but no differences in OE height compared to WT, and the adult KO 
mice have increased proliferation and decreased OE height.  To further examine 
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the differences in OE thickness, we looked at the total number of cells in the OE.  
A total cell count of BCs, immature OSNs, OSNs, and sustentacular cells could 
indicate whether OE height differences were due to changes in cell size or 
changes in total numbers of cells.  Sytox Green was used to label nuclei for 
counting (Fig. 2.3A).  At both P3 and P7, there are no differences in the total 
number of cells in comparable regions of the OE between PACAP KO and WT 
mice (P3; 229.9±6.4 vs 231.9±8.6 cells/150 µm, p=0.865.  P7; 244.5±11.2 vs 
233.8±7.4 cells/150 µm, p=0.386; Fig. 2.3B).  These data suggest that even 
though there is decreased proliferation in P3 mice, the total cell number is not 
changed.  In the adults, PACAP KO mice have significantly fewer cells than WT 
mice in the OE (163±11.4 vs 205.3±13 cells/150 µm, p=0.002; Fig. 2.3B).  These 
data show that the decrease in adult P64 OE thickness is due to decreased 
numbers of cells.  Yet the decrease in OE cell number is not due to a decrease in 
proliferation.  In fact, there was increased proliferation indicating cell death may 
cause the decreased cell number.  The decrease in total cell number in PACAP 
KO P64 mice OE suggests PACAP may function to promote survival. 
 
PACAP and neuronal numbers 
 PACAP is known to promote neuronal maturation and survival (for review 
see Somogyvari-Vigh and Reglodi, 2004).  To investigate differences in the 
ammount of immature OSNs present in WT and PACAP KO mice, we measured 
the area of GAP43 positive label in the OE.  In addition, we counted the number 
of OMP positive cells to quantify the number of mature OSNs.  Representative 
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immunofluorescent images of OMP (red) and GAP43 (green) are shown in Fig. 
2.4A.  Similar to the proliferation results, at P3, PACAP KO mice have less 
GAP43 labeling than WT mice (11.7±0.4 vs 14.6±0.6 pixels/total pixels/150 µm 
OEx100, p=0.023; Fig. 2.4B) but by P7, there were no differences in the 
percentages of GAP43 labeling between PACAP KO and WT mice (15.9±1.3 & 
16.1±0.7, p=0.901; Fig. 2.4B).  At P64, the PACAP KO mice had no difference in 
the percentage of GAP 43 labeling of immature OSNs compared to WT mice 
(10.6±0.8 & 10.8±0.5/150 µm, p=0.686; Fig. 2.4B).  These data show that the 
increased proliferation at P64 in the PACAP KO mice does not lead to increased 
GAP43 expression.  This implies that the daughter cells from increased BC 
division, in adult PACAP KO mice, are either apoptotic themselves, or they 
differentiate into immature OSNs that do not survive and become apoptotic.  
Increased cell death could account for the decrease in OE thickness seen. 
The number of mature OSNs in the OE does not appear to differ between 
PACAP KO and WT mice.  The number of OMP positive OSNs is similar 
between PACAP KO and WT mice at P3 (35.7±0.7 & 33±1.3, p=0.087), P7 
(48.7±2.6 & 43.7±1.1, p=0.124), and adult P64 (42.7±2.0 & 41.2±1.4, p=0.629; 
Fig. 2.4C).  These data demonstrate that PACAP is not required for maturation of 
OSNs in the OE although it appears to influence OSN survival.  Also, in P64 
PACAP KO mice, the increases in DNA synthesis does not lead to increases of 
immature or mature OSNs compared to WT mice.  This could be due to 
increased cell death in the OE, which could lead to increased turnover.  OSN cell 
death causes a release of factors that target the BCs (Holcomb et al., 1995; 
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Mumm et al., 1996; Jia and Hegg, 2010; Jia et al., 2011).  This modulation of OE 
can help maintain the correct number of OSNs in P64 PACAP KO mice. 
 
PACAP KO mice have normal food odor detection 
 We used a behavioral assay to test the olfactory function in adult PACAP 
KO mice.  PACAP KO and WT mice were assessed for their ability to detect and 
locate a piece of malt ball buried in clean bedding.  A mouse with normal 
olfactory function will be able to smell and then locate the malt ball, while 
deficiencies in function will result in a longer latency to find the malt ball.  Training 
consisted of 1 5-min trial a day and to be considered trained, the mice had to find 
the malt ball in less than 60 sec on 3 consecutive trials.  It took similar numbers 
of trials to train both PACAP KO and WT mice (4.4±0.6 &5.3±0.6, p=0.155; Fig. 
2.5A). Once trained, it took a similar amount of time for both PACAP KO and WT 
mice to find the malt ball (23±2 & 19±3 sec, p=0.282; Fig. 2.5B).  These data 
suggest that although the PACAP KO mice have increased cell loss and 
turnover, they have normal ability in detecting and 
locating food odorants. 
 
Discussion 
 In this study, we examined, in vivo, the development and maintenance of 
OE in WT and PACAP KO mice.  We used P3, P7, and P64 mice and measured 
the height of OE along with using immunofluorescence labeling to investigate 
DNA synthesis (BrdU), immature neurons (GAP43), and mature neuronal cell 
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population numbers (OMP).  Adult mice were also tested for olfactory function 
with a food finding behavior test.  
 In P3 PACAP KO mice, the decrease in proliferation leads to a decrease 
in immature OSNs but does not affect the number of mature OSNs or the 
thickness of OE.  At this developmental stage, an excess of immature OSNs are 
present and sending axons towards their target, the olfactory bulb, and only 
those axons that make functional connections survive.  A high level of apoptosis 
occurs during normal early postnatal OE development (Fung et al., 1997), and 
inhibiting this apoptosis, using caspase-3 and caspase-9 KO mice, leads to an 
abnormal increase in OE thickness and OSNs (Cowan and Roskams, 2004).  
The apoptotic cells in normal development have been shown to be OSNs 
(Voyron et al., 1999).  There are at least two possibilities as to how PACAP KO 
mice could have reduced proliferation but a normal number of OMP positive 
OSNs.  One possibility is that the immature OSNs have a decreased level of 
apoptosis. We found reduced GAP43 in PACAP KO indicating that, if anything, 
there is reduced survival of immature OSNs.  Other studies show immature 
OSNs have the highest percentage of apoptosis out of all cell types in WT OE 
(Mahalik, 1996).  A second possibility, given that there is still an abundance of 
neurogenesis occurring in KO mice at P3, is that the decreases in proliferation 
and immature OSNs in PACAP KO mice, although different from WT, may not be 
large enough to affect the OSN population.  Indeed, there is a trend toward more 
OMP cells at P3 in the KO which although not significant, may suggest faster 
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transition to maturity.  Regardless, these studies show that at this early neonatal 
age, PACAP is required to maintain normal proliferation rates in the OE.  
 At P7, the OE is maturing from a developmental to an adult state.  At this 
stage, there are no differences between PACAP KO and WT mice in any of the 
markers we measured.  The difference of effects in P3 and P7 PACAP KO mice 
could be due to changing expression of PACAP from the nerve bundle in P4 
mice to being expressed throughout the OE in adults (Hegg et al., 2003).  The 
absence of PACAP does not cause any morphological abnormalities within the 
P7 OE. 
 In the adult P64 PACAP KO mice, however, there is a deficiency in the 
maintenance of the OE as seen by fewer cells resulting in a decreased OE 
thickness.  Despite the reduced thickness in the PACAP KO mice OE, the overall 
laminar layering is intact.  In addition, the PACAP KO mice have normal olfactory 
function in detecting and locating food odors.  Normal food odor detection was 
also found in animals in which the PACAP receptor, PAC1, was deleted: 
however, in those animals, gender recognition was impaired (Nicot et al., 2004). 
Future studies will investigate gender recognition in PACAP KO mice. 
Despite the observed decrease in OE thickness, P64 PACAP KO mice 
display increased neuronal proliferation as measured by BrdU.  One explanation 
could be that normally, PACAP promotes the survival of BC and immature OSNs.  
Although found throughout the OE, the highest expression of PACAP and PAC1 
receptors are on the BCs and immature OSNs (Hansel et al., 2001).  In KOs, the 
lack of trophic PACAP support could lead to increased apoptosis.  Cell death 
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would then signal the BCs to increase proliferation.  However, in the PACAP KO 
mice, it seems the increased proliferation is not enough to overcome the loss of 
cells.  This is consistent with our height data showing that the lower third layer in 
the OE is most reduced in PACAP KO mice.  This is also consistent with a study 
showing the highest levels of apoptosis occur in the immature OSNs in adult rats 
under normal housing conditions (Mahalik, 1996).  Similarly, Kondo et al. (2010) 
showed that aged 16-month-old mice had a thinner OE as well as a reduction in 
total cells while maintaining a normal OSN population, and the reduction in OE 
thickness was a result of increased apoptosis in the immature OSNs.  Although 
we did not see a change in GAP43 staining, the increased turnover could lead to 
increased GAP43 levels in fewer numbers of cells so the average GAP43 
staining would not necessarily change between WT and PACAP KO OE. Clearly, 
direct measure of apoptosis will be necessary to conclusively determine which 
cell types are most sensitive to loss of PACAP.  To date, we have not been able 
to reproducibly measure apoptosis in the OE of WT and PACAP KO mice using 
TUNEL labeling, but future studies employing caspase makers will be 
undertaken. 
 The deficits seen in survival of PACAP KO mice OE could be due to an 
increased inflammatory response.  Cell death in the OE initiated by bulbectomy, 
or OSN target removal, causes macrophage recruitment in the OE (Getchell et 
al., 2002b; Kwong et al., 2004).  The recruitment of macrophages is important in 
the degeneration and regeneration of the OE (Getchell et al., 2002a; Kwong et 
al., 2004).  A loss of macrophages in the OE results in increased apoptosis in 
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both sham and bulbectomized mice (Borders et al., 2007).  PACAP plays a role 
in inflammation and could be one mechanism of regulating OE cell survival.  
PACAP can regulate the expression of chemokines in activated macrophages 
(Delgado et al., 2002) and delayed axon regeneration using a facial nerve injury 
was seen in PACAP KO mice due to a rise in pro-inflammatory cytokine 
expression (Armstrong et al., 2008).  The ability of PACAP to regulate 
inflammatory responses and the role of inflammatory response to OE damage 
could be one route whereby PACAP influences the integrity of adult OE.  The 
role of inflammation in PACAP KO mice will be investigated in Chapter 3. 
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Figure 2.1. Comparisons of OE height between WT and PACAP KO mice at 
different ages.  (A) H&E staining of P7 WT OE.  Boxes outline the areas imaged 
for analysis.  Scale bar = 1 mm.  (B) Immunofluorescent image of P7 WT OE.  
The 3 vertical white lines depict how OE height was measured.  The white 
dashed line depicts the basement membrane.  Three measurements from each 
image were taken and averaged as the height for that image.  Scale bar = 50 µm.  
(C) Quantification of OE height.  PACAP KO mice (solid bars) OE height is not 
affected at P3 or P7 but is significantly decreased in adults compared to WT 
(open bars).  OE height was measured from 6 areas per section, 2 sections per 








































Figure 2.2. Comparisons of proliferation between WT and PACAP KO mice at 
different ages.  (A) BrdU labeling (red) in OE of PACAP KO and WT mice.  White 
dashed line depicts the basement membrane.  Scale bar = 20 µm.  (B) 
Quantification of BrdU incorporation.  PACAP KO (solid bars) and WT (open 
bars) were injected with 50 mg/kg of BrdU 2 hr before fixation.  The number of 
BrdU positive nuclei per 150 µm length of basement membrane were counted 
from all regions and averaged across animals.  At P3, PACAP KO mice have 
significantly fewer BrdU-labeled cells than WT but by P7, the PACAP KO and WT 
mice have a similar number of BrdU-labeled cells.  However, in adults, PACAP 
KO mice have significantly increased number of BrdU-labeled cells compared to 
























































Figure 2.3. Comparison of the total number of cells in the OE between WT and 
PACAP KO mice at different ages.  (A) Sytox Green (green) stains the nuclei of 
all cells in the OE.  White dashed line depicts the basement membrane.  Scale 
bar = 20 µm.  (B) Quantification of total cell number in the OE between WT (open 
bars) and PACAP KO (solid bars) mice.  The total number of cells per 150 µm 
length of basement membrane were counted from all regions and averaged 
across animals.  At P3 and P7 there is no difference in the number of cells in the 
OE between PACAP KO and WT mice.  However, adult PACAP KO mice have 




















































Figure 2.4.  Comparison of mature and immature OSNs in PACAP KO versus 
WT mice at different ages. (A) Immunofluorescent labeling is shown for mature 
OSNs expressing OMP (red) and immature OSNs expressing GAP43 (green).  
White dashed line depicts the basement membrane.  Scale bar = 20 µm.  (B) 
Quantification of mature OSNs in the OE of WT (open bars) and PACAP KO 
(solid bars) mice.  The number of OMP positive cells were counted per 150 µm 
length of OE for all regions and averaged across animals.  The number of OMP-
labeled cells did not differ between PACAP KO and WT mice at any age.  P>0.05 
versus WT.  (C) Quantification of immature OSNs in the OE of WT (open bars) 
and PACAP KO (solid bars) mice.  The amount of GAP43 label was determined 
by finding the percent of positive labeled pixels from the total number of pixels in 
the OE.  At P3 PACAP KO mice have decreased immature OSN label than WT 
mice but by P7 the difference has disappeared.  As adults, PACAP KO mice 
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Figure 2.5.  Comparison of olfactory function between WT and PACAP KO mice.  
PACAP KO and WT mice were assessed for food odorant detection by their 
ability to find a malt ball buried in clean bedding.  (A) It took similar number of 
trials to train both adult PACAP KO and WT mice.  (B) Once trained, it took a 
similar amount of time for both PACAP KO and WT mice to find the malt ball.  
Based on this simple assay, the PACAP KO mice appear to be able to detect, 































THE EFFECTS OF PACAP ON OLFACTORY EPITHELIUM  
REGENERATION AFTER INJURY 
 
Abstract 
 The olfactory system provides an excellent model for the study of adult 
mammalian neurogenesis.  The olfactory epithelium (OE) has the unique ability 
to regenerate functional olfactory sensory neurons (OSNs) throughout life. 
Exposure to environmental toxins causes apoptosis of OSNs, resulting in a 
continuous low level of OSN turnover.  Additionally, the OE can regenerate after 
an insult causing widespread damage and loss of OSNs.  Pituitary adenylate 
cyclase-activating polypeptide (PACAP) plays many roles in neurogenesis and 
may influence OSN turnover in the OE.  In vitro studies have shown that PACAP 
is protective and decreases levels of apoptosis in the OE.  Insults to the OE lead 
to inflammatory responses important for OSN turnover.  PACAP has been shown 
to have anti-inflammatory effects, although the effects of PACAP on inflammation 
in the OE are unknown.  We used methimazole, an olfactotoxin, as an insult to 
compare the loss and regeneration of cells in the OE between PACAP knock-out 
(KO) and wild-type (WT) mice.  To test the ability to detect food odorants, mice 
were trained in a behavioral food localization task.  Food detection latency was 
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measured before and after a single methimazole injection.  Directly after 
behavioral testing, OE tissue was collected for Western blot and quantitative 
reverse transcriptase-PCR (qRT-PCR) to measure levels of neuronal and 
inflammatory markers, in addition to histological analysis.  PACAP KO and WT 
mice food localization latency is similar before insult.  Additionally, PACAP KO 
mice tended to express increased neuronal and proliferative markers in the intact 
OE, suggesting increased OSN turnover.  At 4 hr after insult, PACAP KO mice 
had a larger decrease in OSN protein levels and increased expression of 
inflammatory markers.  At 24 hr after insult, PACAP KO mice were significantly 
more impaired at the food localization task than WT mice.  However, 
inflammatory marker expression levels did not differ between WT and PACAP 
KO mice.  After 48 hr, the WT and PACAP KO mice both showed behavioral 
deficits.  72 hr after insult, PACAP KO mice were significantly faster at locating 
food and show increased expression of a proliferation marker, Mash1.  One week 
after injury, WT and PACAP KO mice show similar food localization latency, and 
by 2 weeks postinsult both WT and PACAP KO have recovered to baseline pre-
insult food localization latencies.  From this work, we determined that the 
absence of PACAP leads to an increased inflammatory response and faster 
degeneration of the OE after injury. The faster recovery we observed in the 
PACAP KO mice may be due to the increased turnover of OSNs.  We conclude 






 The OE is a pseudostratified epithelium containing OSNs that function to 
detect odors from the environment.  The OE is comprised of 3 main cell types: 
basal stem cells (BCs), OSNs, and sustentacular cells.  A basement membrane 
separates the neuroepithelium from the glands, nerve bundles, and blood 
vessels of the olfactory submucosa and forms the basal barrier of the OE.  
Located above the basement membrane is a population of two types of BCs, the 
globose and horizontal cells.  The horizontal cells include the pluripotent slowly 
dividing stem cells while the globose cells divide rapidly to generate and replace 
cells in the OE. Located just above the BC layer, the immature OSNs extend 
GAP43 positive axons to the olfactory bulb and migrate apically in the OE as they 
mature.  Sustentacular cells provide glial-like support to OSNs.  Their somas 
form the most apical layer of the OE and their end-feet envelope BCs along the 
basement membrane.  The mature OSNs each have a dendrite that extends to 
the apical surface of the OE where cilia, containing the odorant receptors and 
transduction machinery, are exposed to odorant molecules in the nasal cavity 
and an axon that extends basally through the submucosa and synapses in the 
olfactory bulb. 
 The OE has the remarkable ability to regenerate after injury or cell death, 
even in adult mammals.  Regeneration can occur following cell death caused by 
exposure to damaging environmental airborne toxins and xenobiotics, or induced 
apoptosis from a lesion (for review see Schwob, 2002).  Damaging 
environmental exposure causes OSNs and sustentacular cells to become 
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apoptotic or necrotic.  The damaged cells then release ATP (and possibly other 
signaling molecules) that stimulate BC proliferation (Hegg and Lucero, 2006; Jia 
et al., 2009) and eventual replacement of the apoptotic OSN.  This tightly 
regulated turnover and replacement of damaged cells maintains a constant 
number of OSNs within the OE.  Even when damage to the OE is widespread 
from lesion or insult, the OE retains the capacity to regenerate all cell types, 
including mature, functional neurons.  Understanding this remarkable capability 
for adult neurogenesis is vital to developing therapeutic targets against neuronal 
degeneration and injury. 
 PACAP is a pleiotropic peptide that is part of the vasointestinal peptide-
glucagon secretin peptide superfamily.  PACAP is involved in many aspects of 
neurogenesis and may influence OSN turnover in the OE.  PACAP is detected, 
along with its receptor (PAC1), in developing and adult OE (Hansel et al., 2001; 
Hegg et al., 2003) and olfactory bulb (Jaworski and Proctor, 2000).  In the adult 
mouse OE, PACAP is found in all cells throughout the OE with the most intense 
label in the BCs (Hegg et al., 2003).  In vitro studies have examined the effects of 
PACAP on proliferation, maturation, and survival of cells from the OE.  In 
neonatal rat primary OE cultures, PACAP increases proliferation and the number 
of immature OSNs (Hansel et al., 2001).  PACAP also increases OSN 
excitability, which could be one possible mechanism of survival, since OSN 
activity has been demonstrated to be involved in survival of neurons in the OE 
and olfactory bulb (Petreanu and Alvarez-Buylla, 2002; Watt et al., 2004).  In 
mouse OE primary cultures or slices, PACAP increases intracellular Ca+2 (Hegg 
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et al., 2003).  The increase in intracellular Ca+2 may be important for survival by 
resulting in excitation of the cell or activation of downstream effectors that 
regulate transcription.  PACAP suppression of K+ channel expression in mouse 
OSNs (Han and Lucero, 2006) correlates with decreases in caspase activation 
and increased survival (Han and Lucero, 2005).  In addition to promoting survival 
by regulating cell excitability, PACAP can protect against pro-apoptotic factors.  
In olfactory cell lines and mouse neonatal OE slices, PACAP protects against 
TNFα-induced apoptosis (Kanekar et al., 2010).  Furthermore, mice lacking all 
amidated peptides, including PACAP, have deceased OE thickness.  Together, 
these data suggest a role for PACAP in turnover and maintenance of the OE in 
vivo. 
 PACAP may also indirectly affect OE survival and regeneration by 
modulating inflammatory responses.  Inflammatory responses are involved in 
OSN turnover in the OE.  Removal of OSN axon target, or bulbectomy, causes 
OSN apoptosis that increases levels of the chemokine macrophage inflammatory 
protein (MIP-1α) which results in increased recruitment of macrophages to the 
OE (Getchell et al., 2002a; Getchell et al., 2002b; Kwong et al., 2004). The 
recruitment of macrophages to the OE is important for the regeneration of OSNs.  
For example, in vivo studies have shown that disruption of the inflammatory 
response or depletion of macrophages leads to increased apoptosis and 
decreased numbers of mature OSNs and proliferating BCs in the OE after 
bulbectomy (Getchell et al., 2006; Borders et al., 2007b).  These studies indicate 
the importance of the inflammatory response in OE damage and repair. 
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 PACAP has been shown to be capable of influencing inflammatory 
responses (for review see Leceta et al., 2000; Delgado et al., 2003a).  PACAP 
can inhibit production of pro-inflammatory chemokines such as MIP-1α, TNFα, 
and IL-6 (Delgado et al., 1999; Delgado et al., 2002; Delgado et al., 2003b).  
Additionally, an in vivo study demonstrated that intranasal administration of 
maxadilan, a PAC1 receptor agonist, to ovalbumin-induced asthma mice has an 
anti-inflammatory effect (Lauenstein et al., 2011).  Furthermore, axon 
regeneration was delayed after facial nerve injury in PACAP KO mice due to an 
increase in pro-inflammatory cytokine expression (Armstrong et al., 2008).  
Therefore, the involvement of PACAP in inflammation is one mechanism in which 
PACAP can influence turnover in the OE. 
 To examine the effects of PACAP in OE regeneration in vivo, we used 
methamizole, an antithyroid drug that causes degeneration of the OE, to study 
factors involved in the degeneration and regeneration on the OE in PACAP KO 
and WT mice.  A simple olfactory behavioral task was used to assess for the 
onset of and recovery from anosmia. We also investigated changes in neuronal 
and inflammatory proteins as well as changes in neuronal, proliferative, 




 All animal procedures were approved by the University of Utah 
Institutional Animal Care and Use Committee, and all applicable guidelines from 
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the National Institutes of Health (NIH) Guide for Care and Use of Laboratory 
Animals were followed.  C57BL/6 PACAP heterozygote mice were obtained from 
Dr. N. Sherwood (Univ. of Victoria) for breeding (Gray et al., 2001).  
Heterozygote breeding pairs and pups were maintained at 30°C to prevent 
hypothermia in the PACAP KO mice (Gray et al., 2002).  Once weaned at 3-4 
weeks, littermates were group housed at 21°C in same sex cages on 12 hr 
light/dark cycle with food and water ad libitum.  Tail biopsies were geneotyped by 
Transnetyx (Cordova, TN).  For olfactory behavior studies, 27 WT and 29 
PACAP KO mice were used.  Tissue was collected for qRT-PCR, Western blots, 
and immunohistochemistry. 
 
Treatment and tissue collection 
 One-year-old WT and PACAP KO C57BL/6 mice were injected with 
Methamizole (50 mg/kg, Sigma, St. Louis, MO) and sacrificed at either 4 hr, 24 
hr, 72 hr, 1 week, or 2 weeks postinjection.  Wild-type and PACAP KO mice used 
for tissue sections were perfusion fixed with 4% Formal-Fixx (FF) (Thermo 
Scientific, Waltham, MA) and the skin and lower jaw were removed from the 
head.  The heads were postfixed in 4% FF at 4°C overnight.  Adult heads were 
rinsed in PBS and decalcified for 2 hr (Rapid decalcifier, Apex Engineering 
Products Corp., Plainfield, IL).  The heads were rinsed twice in PBS and serially 
cryo-protected in 15% and 30% sucrose at 4°C overnight.  Heads were 
embedded in Tissue-Tek optimal cutting temperature (OCT) (Fisher Scientific, 
Pittsburgh, PA) and frozen in an ethanol/dry ice bath.  Frozen coronal sections 
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(10 µm thick) of OE were cut on a cryostat and serially collected on 
Superfrost/Plus slides (Fisher Scientific, Pittsburgh, PA).  For isolations of protein 
or mRNA, the dorsal medial OE was dissected out in ice cold Ringer’s and frozen 
at -80°C (protein) or stored in RNA later (mRNA) (Ambion, Carlsbad, CA) until 
used. 
 
Hematoxylin and Eosin staining 
 Subsets of frozen sections were stained using Harris Hematoxylin (Sigma, 
St. Louis, MO) and counterstained in Eosin (Sigma). Briefly, slides were hydrated 
in PBS, soaked 3 min in hematoxylin, decolorized 10 sec in acid alcohol (0.025% 
HCl in 70% EtOH), rinsed in H2O, blued for 10 sec in 0.1% lithium carbonate, 
rinsed in running tap water 5 min, counterstained in eosin for 20 sec, dehydrated 
twice each in 95% and 100% EtOH, cleared 2x5 min in xylene and mounted with 
the xylene based mounting medium DPX (BDH Laboratory Supplies, Poole, 
England).  Slides were imaged on a Nanozoomer Digital Pathology system 2.0 
(Hamamatsu, Hamamatsu City, Japan) and analyzed using system software. 
 
Food retrieval task 
 All behavioral tests were performed blind to genotype. To test olfactory 
function, adult mice were individually trained to locate a piece of chocolate 
covered malt ball (Whoppers™, Hershey, PA) buried in clean bedding.  A mouse 
with normal olfactory function will be able to smell or detect and then locate the 
malt ball and deficiencies in function will result in a longer latency to locate the 
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malt ball.  Each mouse was acclimated to the testing room in a clean cage for 30 
min before starting the task.  Mice were placed in a new clean cage with 3 cm of 
clean corncob bedding and allowed to explore for 5 min.  A piece of malt ball was 
randomly buried in the bedding and the mouse was allowed to explore for 
another 5 min.  The latency to find the malt ball was recorded.  Mice performed 1 
trial a day and were considered trained when they found the malt ball in less than 
60 sec for 3 consecutive trials.  Once trained, mice were injected with 
methimazole and re-examined at time points ranging from 4 hr to 2 weeks later.  
Statistical significance between WT and PACAP KO mice was determined using 
Student’s t-tests with P values < 0.05.  Data is reported mean ± sem. 
 
Western blot 
 Tissue was sonicated and homogenized in RIPA buffer (Santa Cruz 
Biotech, Santa Cruz, CA) containing protease inhibitors.  The homogenates were 
centrifuged at 9,000 x g at 4°C for 10 min, the supernatant was collected into a 
new tube and spun at 9,000 rpm at 4°C for 10 min to remove the insoluble 
fraction.  Protein samples (15 µg) were denatured in Laemli buffer at 95°C for 5 
min and subjected to SDS-PAGE electrophoresis on a 12% polyacrylamide gel 
and then transferred to PVDF membranes (Bio-Rad, Hercules, CA).  Membranes 
were blocked in Rapid block (Amresco, Solon, OH) for 5 min at room temp and 
incubated in primary antibody (anti-OMP and -GAP43 at 1:10,000, and anti-Iba1 
at 1:1,000) overnight at 4°C.  After washing, membranes were incubated with 
secondary antibodies linked to horseradish peroxidase (1:20,000) (Thermo 
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Scientific, Rockford, IL).  Membranes were developed by chemiluminescence 
and imaged on FluorChem imager (Cell Biosciences, Santa Clara, CA).  System 
software was used to measure density of selected bands. 
 
Qualitative reverse transcriptase-PCR 
 Total RNA was isolated from OE tissue collected from the dorsal recess 
area, using the RNeasy Kit from Qiagen (Valencia, CA). For each sample, 1 µg 
of total RNA was reverse transcribed using the RT2 First Strand Kit 
(SABiosciences, Frederick, MD) according to the manufacturer’s protocol. 
Expression levels for each gene of interest were analyzed by qRT-PCR.  PCR 
reactions were performed using Power SYBR Green PCR Master Mix (Applied 
Biosystems) with 0.4 µl sample cDNA and 200 nM each forward and reverse 
primer, in a final volume of 22 µl. PCR parameters consisted of an initial 10 min 
incubation at 95°C, followed by 40 cycles for amplification (95°C for 20 sec, 60°C 
for 1 min).  All PCR reactions were performed in triplicate using the BioRad 
Chromo4 Detector and Opticon Monitor software. Amplification specificity was 
monitored by melting curve analysis.  
 A relative quantification approach was used in this study to describe 
changes in mRNA expression of the target gene in a sample. Expression levels 
were normalized to β-actin expression. The Ct values for β-actin for the untreated 
and methimazole-treated wildtype and PACAP knockout OE tissues were in 
close range to each other. The relative transcript abundance for a target gene 
was calculated by first determining the ΔCT in the untreated tissue and then 
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differences between the untreated and methimazole-treated tissues at each time 
point were calculated as ΔΔCT	  (	  ΔCT	  methimazole	  –	  ΔCT	  untreated).	  The fold change in 
expression (relative abundance) was calculated using the formula 2-ΔΔCT and 
reported as mean +/- SE.  See Table 3.1 for forward and reverse primers used. 
 
Results 
Methimazole treatment causes OE damage in WT  
and PACAP KO mice 
 The OE has the ability to regenerate after insult.  To compare the 
regenerative ability in PACAP KO and WT mice, we injured the OE with the anti-
thyroid drug methimazole.  Methimazole causes apoptosis via caspase-3 
activation in the rat OE (Sakamoto et al., 2007).  Cell death is seen as early as 2 
hr after methimazole insult in sustentacular cells (Bergstrom et al., 2003).  We 
injected WT and PACAP KO mice with methimazole (50 mg/kg) and looked at 
the morphology and structure of the OE 24 hr, 72 hr, and 2 weeks after insult 
(Fig. 3.1).  After 24 hr, the OE is detaching from the basement membrane in WT 
mice.  This detachment of the OE has been shown to occur in rats (Sakamoto et 
al., 2007) and mice (Suzukawa et al., 2011; Xie et al., 2011) 1 day after 
methimazole injection.  In comparison, the OE in PACAP KO mice is more 
extensively damaged and has already sloughed off at 24 hr after insult.  At 72 hr 
postinsult, only a layer of BCs remains in WT mice OE.  However, the OE in 
PACAP KO mice has started to recover and is a few cells thick although it is 
highly disorganized.  At 2 weeks after methimazole insult, both WT and PACAP 
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KO mice have regained the structure and organization of the OE; however, the 
OE is still thinner than pretreatment.  The greater destruction at 24 hr in PACAP 
KO mice along with the increased regeneration at 72 hr compared to WT suggest 
that the degradation and regeneration of the OE in PACAP KO mice happens 
more quickly than in WT mice.   
 
Methimazole-induced anosmia in WT and PACAP  
KO mice 
 Methimazole insult leads to olfactory dysfunction.  Mice injected with 
methimazole have increased intake of a vanillin solution, which is typically 
avoided, indicating reduced olfactory function (Sakamoto et al., 2007; Suzukawa 
et al., 2011).  To test for differences in methimazole-induced anosmia in WT and 
PACAP KO mice, we used a simple behavioral task.  For this task, mice were 
trained to locate a piece of malt ball buried in clean bedding.  After mice were 
trained, they were injected with methimazole and tested again at 24 hr, 48 hr, 72 
hr, 1 week, and 2 weeks later (Fig. 3.2).  Prior to injection, it takes a similar 
amount of time for PACAP KO and WT mice to find the malt ball (23±2 vs 19±3 
sec, respectively, p=0.282).  One day postmethimazole injection, PACAP KO 
mice are significantly slower at finding the malt ball compared to WT (≥300±0 vs 
248±28 sec, p=0.047; Fig. 3.2).  In fact, none of the PACAP KO mice located the 
malt ball within the 5 min trial.  Although the WT mice can still locate the malt 
ball, they are impaired compared to pre-insult times.  These results are 
consistent with histological analyses, where at 24 hr the OE was more damaged 
  
70 
in PACAP KO mice (Fig. 3.1).  After 48 hr, the WT mice are not able to find the 
malt ball.  However the PACAP KO mice have already started to recover and can 
locate the malt ball but are still impaired compared to preinsult times and not 
significantly different from WT (214±44 vs 300±0 sec, p=0.184; Fig. 3.2).  At 72 
hr postinsult, WT mice are significantly slower than PACAP KO mice at locating 
the malt ball (278±22 vs 136±40 sec, p=0.009; Fig. 3.2).  One week after injury, 
the WT mice have recovered to a similar extent as PACAP KO mice (112±94 vs 
76±46 sec, p=0.705; Fig. 3.2).  After 2 weeks, PACAP KO and WT mice have 
both fully recovered the ability to locate the malt ball (16±4 vs 18±3 sec, p=0.773; 
Fig. 3.2).  These behavioral results support the observed morphological damage 
and suggest that PACAP KO mice have faster loss of OE function, suggesting 
PACAP promotes survival in the OE.  The faster recovery from anosmia in 
PACAP KO mice may be due to the increase in basal levels of proliferation and 
OSN turnover observed in untreated PACAP KO mice. 
 
Protein changes after methimazole in WT  
and PACAP KO mice 
 To further characterize the degeneration of the OE after methimazole in 
WT and PACAP KO mice, we looked at changes in protein levels.  We used 
Western blots of OMP and GAP43 to examine loss and recovery of OSNs and 
ionized calcium binding adaptor molecule (Iba1), a marker of macrophages 
residing in OSN nerve bundles (Smithson and Kawaja, 2010) to measure 
inflammation.  Examples of protein levels before and after methimazole insult are 
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shown in Fig. 3.3A.  Band densities were normalized to actin for quantification; 
however, due to low numbers of animals (n=2) at some time points, no statistical 
analyses were performed between WT and PACAP KO mice.  PACAP KO mice 
had a larger decrease in OMP at 4 hr after methimazole compared to WT mice.  
A comparable decrease in WT OMP was not seen until 72 hr after insult.  At 1 
week, PACAP KO mice are starting to increase levels of OMP (Fig. 3.3B).  These 
results are consistent with the H&E staining and behavior showing that PACAP 
KO mice have faster onset and recovery of methimazole-induced anosmia.  Up 
to 24 hr after injury, GAP43 levels are decreased in both WT and PACAP KO 
mice.  However, at 72 hr after insult, PACAP KO mice show increasing levels of 
GAP43 while the WT is still decreased.  At 1 week post-injection, both PACAP 
KO and WT mice have increased levels of GAP43 (Fig. 3.3C).  The earlier 
increase in GAP43 at 72 hr in PACAP KO mice is also consistent with PACAP 
KO mice recovering faster than WT mice after insult.  The presence of protein, 
although low, at 72 hr after insult could be protein from within OSN nerve bundles 
located in the submucosa, which is likely included in the tissue collection.  The 
macrophage marker protein, Iba1, had similar increases peaking at 24 hr after 
insult and then dramatic decreases at 72 hr in both PACAP KO and WT mice 
(Fig. 3.3D).  Although Iba1 is found in the nerve bundle, the macrophages could 
move into the OE where apoptosis is starting.  Then at 72 hr after insult, when 
the OE has degenerated, the Iba1 protein is lost.  The similarities in Iba1 levels in 
the OE of PACAP KO and WT mice suggests that PACAP is not required for 
initiation of an inflammatory response to methimazole insult. 
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Changes in mRNA expression after methimazole in  
PACAP KO and WT mice 
 Apoptosis in the OE, resulting from bulbectomy, causes changes in gene 
expression (Getchell et al., 2005).  Bulbectomy also induces an inflammatory 
response with recruitment of macrophages to the OE (Getchell et al., 2002a; 
Getchell et al., 2002b; Kwong et al., 2004).  To further investigate differences in 
PACAP KO and WT mice responses to methimazole insult, we examined levels 
of OE neuronal, proliferative, apoptotic, and inflammatory factors using qRT-
PCR.  We first calculated the levels of mRNA expression in untreated PACAP 
KO mice as fold changes compared to untreated WT mice (Fig. 3.4A).  Untreated 
PACAP KO mice have increased expression levels of Omp and Gap43 
compared to the 95% confidence interval (95% CI) of WT mice for those genes 
(Omp: 1.1, 95% CI (1.5, 1.6); Gap43: 4.1, 95% CI (4.6, 5.4).  Expression of 
Mash1, a transcription factor transiently expressed in OE early progenitors, and 
Cox2, an inducible pro-inflammatory enzyme, are increased in untreated PACAP 
KO mice compared to the 90% CI for WT.  Aside from Cox2, there were no 
differences in expression in other inflammatory (Iba1, Ccl3, Il6, Tnfα) or pro-
apoptotic (Bax) factors.  These findings of increased expression of proliferative 
and neuronal genes in PACAP KO mice suggest an increase in OSN turnover in 
the OE possibly due to reduced survival in the absence of PACAP. 
 We also examined gene expression after methimazole treatment to look at 
changes in fold expression during OE degeneration between PACAP KO and WT 
mice.  Figure 3.4 (B-J) shows the fold changes for each time point (4, 24, and 72 
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hr after insult) compared to untreated levels from the same genotype.  
Differences in changes of mRNA expression were examined by comparing the 
fold change of PACAP KO mice to the CI of the fold change of WT mice at that 
time point.  At 24 and 72 hr after methimazole insult, expression of Omp and 
Gap43 was decreased to extremely low levels in both the PACAP KO and WT 
mice (Fig. 3.4B,C).  The low levels of Omp and Gap43 expression after insult are 
most likely due to the cell death and subsequent loss of these cells from the OE.  
Mash1 is reduced at 4 and 24 hr after insult comparably in PACAP KO and WT 
mice.  However, at 72 hr, PACAP KO mice had a larger increase compared to 
WT at the 95% CI (Fig. 3.4D).  The greater increase of Mash1 implies the 
PACAP KO mice have increased proliferation and therefore recovery compared 
to WT mice at 72 hr after methimazole.  Increased expression levels of Bax are 
similar between PACAP KO and WT mice at 4 and 24 hr after insult, but at 72 hr, 
the increase in Bax expression in PACAP KO mice is less than the increase in 
WT mice (95% CI, Fig. 3.4E).  The lower Bax expression implies a lower level of 
apoptosis in PACAP KO mice compared to WT at 72 hr after insult.  A decrease 
in apoptosis supports the idea that PACAP KO mice are in a more regenerative 
state than WT mice at this time. 
 Changes in expression of inflammatory factors after methimazole insult 
were investigated in PACAP KO and WT mice.  We investigated changes in Iba1, 
which is expressed in OSN nerve bundles and is up-regulated in activated 
macrophages.  We also looked at expression levels of Ccl3, which produces the 
MIP-1α chemokine, Il6, and Tnfα since PACAP can inhibit the production of 
  
74 
these cytokines (Delgado et al., 1999; Delgado et al., 2002; Delgado et al., 
2003b).  We also examined Cox2 expression since it is an inducible pro-
inflammatory enzyme.  Expression of Iba1 was surprisingly decreased in both 
PACAP KO and WT mice 4 hr and then increased at 24 and 72 hr after injury.  At 
24 hr after methimazole treatment, PACAP KO mice had a larger increase in 
Iba1 expression compared to the 90% CI for WT mice (Fig. 3.4F).  PACAP KO 
mice also have a larger increase in Ccl3 expression 4 hr after insult compared to 
the 95% CI for WT mice.  However, at 24 hr postinsult, the PACAP KO mice 
have a smaller increase in expression compared to the 90% CI for WT mice but 
by 72 hr after methimazole increases in Ccl3 expression are smaller between 
PACAP KO and WT mice (Fig. 3.4G).  Although methimazole causes dramatic 
116±28 and 72±22 fold increases in Il6 expression respectively in PACAP KO 
and WT mice after 4 hr, the increase in PACAP KO mice was greater than WT at 
the 95% CI.  Similar changes in Il6 expression, which were decreased compared 
to 4 hr but still elevated compared to untreated, were observed between PACAP 
KO and WT mice at 24 and 72 hr after insult (Fig. 3.4H).  At 4 hr after 
methimazole treatment, Tnfα expression is decreased, but the PACAP KO mice 
have less of a decrease compared to 95% CI for WT.  At 24 and 72 hr after 
insult, Tnfα expression changes are similar between PACAP KO and WT mice 
(Fig. 3.4I).  PACAP KO mice also have larger increase in Cox2 expression at 4 
and 72 hr, but not 24 hr, after injury compared to the 95% CI for WT mice (Fig. 
3.4J).  The larger fold change in all inflammatory factors, except Iba1, at 4 hr 
after insult in PACAP KO mice suggest a greater inflammatory response occurs 
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following methimazole insult in PACAP KO mice.  A stronger inflammatory 
response may mediate the faster OE degeneration observed in PACAP KO mice 
after methimazole insult. 
 
Discussion 
 In this study, we examined the effects of PACAP on adult OE regeneration 
in vivo.  We used the anti-thyroid drug methimazole to induce apoptotic 
(Sakamoto et al., 2007) degeneration of the OE (Bergman and Brittebo, 1999; 
Bergstrom et al., 2003; Suzukawa et al., 2011; Xie et al., 2011).  The 
methimazole-induced destruction of the OE initiates BC division and 
regeneration.  We compared the morphology, olfactory behavior, and changes in 
protein and mRNA levels after methimazole insult between PACAP KO and WT 
mice to better understand the role of PACAP in adult OE degeneration and 
neurogenesis. 
 Histological analysis on OE from PACAP KO and WT mice was performed 
to examine the morphology of the OE after methimazole insult.  In WT mice, at 
24 hr postmethimazole injection, the OE is beginning to detach from the 
basement membrane.  At 72 hr after insult, the WT OE consists of only a thin 
layer of BCs.  However, by 2 weeks after injury, the OE is clearly regenerating 
with multiple organized cell layers but is still thinner than untreated OE.  These 
results are consistent with studies showing OE detachment from the basement 
membrane 24 hr after methimazole treatment (Sakamoto et al., 2007; Xie et al., 
2011) as well as a very thin and disorganized OE at 4 days and restoration of 
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organization and multiple cell layers at 11 and 14 days after insult (Bergman and 
Brittebo, 1999; Suzukawa et al., 2011).  The thin layer of cells seen at 4 days 
after injury could be a result of the start of cell division of the layer of BCs present 
72 hr after insult.  In comparison to WT mice, PACAP KO mice seem to have a 
faster degeneration and regeneration of the OE after insult.  At 24 hr after 
methimazole insult, the OE in PACAP KO mice has already detached and a 
disorganized layer 1 to 2 cells thick is present, similar to WT at 4 days after insult 
(Bergman and Brittebo, 1999; Suzukawa et al., 2011).  An increase in thickness 
due to increasing cell numbers was present in PACAP KO mice 72 hr after injury; 
however, the OE was still disorganized.  By 2 weeks post-methimazole injection, 
the PACAP KO and WT mice were at similar stages of recovery.  The presence 
of increased cell numbers at 72 hr postinsult in PACAP KO mice is in contrast to 
the WT at this time, and suggests that PACAP KO mice have a faster turnover of 
damaged OE compared to WT mice.   
 PACAP KO and WT mice were behaviorally tested to study differences in 
olfactory function before and during the regenerative process.  We tested the 
ability of PACAP KO and WT mice to locate a buried malt ball.  Methimazole 
administration has been shown to cause defects in olfactory behavior in WT rats 
and mice, but PACAP KO olfactory function has not previously been examined.  
After methimazole treatment, rats were slower at finding a food pellet (Genter et 
al., 1996) and mice had increased intake of a vanillin solution, which mice 
normally avoid (Sakamoto et al., 2007; Suzukawa et al., 2011).  Before 
methimazole insult, PACAP KO and WT mice had similar latencies to locating a 
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buried malt ball.  However, after OE insult, the PACAP KO mice have a faster 
onset of anosmia seen at 24 hr compared to WT mice.  This implies that damage 
occurs faster or more widespread in PACAP KO mice and suggests a 
neuroprotective role for PACAP in the normal adult OE.  Wild-type mice are not 
anosmic until 48 hr after insult, but at this time the PACAP KO is recovering and, 
although impaired, can now locate the malt ball.  Additionally, the PACAP KO 
mice show an earlier regenerative state compared to WT mice by having 
significantly shorter latencies at locating the malt ball 72 hr after methimazole 
insult.  However, 1 week after insult, the WT mice had recovered to similar 
latency times as PACAP KO mice.  The ability of the WT mice to locate the malt 
ball is consistent with the appearance of OSNs in the WT OE at 1 week after 
methimazole treatment (Sakamoto et al., 2007; Suzukawa et al., 2011).  By 2 
weeks after injury, both WT and PACAP KO mice were recovered to pre-insult 
times.  These results are also consistent with the differences in methimazole-
induced morphological changes between PACAP KO and WT mice.  The fact 
that the PACAP KO OE can regenerate after injury suggests that PACAP is not 
required for proliferation in the adult OE.  The earlier degeneration time in 
PACAP KO mice compared to WT mice following methimazole insult implies that 
PACAP may increase survival of OE in vivo. 
 To further our understanding of PACAP’s role in survival in the OE, we 
examined changes in protein and mRNA expression levels between PACAP KO 
and WT mice before and after methimazole insult.  Before methimazole 
treatment, PACAP KO mice have increased expression of Omp, Gap43, Mash1, 
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and Cox2 compared to WT mice.  The largest differences were seen in Mash1 
followed by Gap43 expression, suggesting the PACAP KO mice are primed for 
and/or are actively undergoing OSN turnover.  An increase in neurogenesis in 
PACAP KO mice could be the result of increased cell death in the OE.  Increases 
in expression of Omp in the PACAP KO mice are most likely a result of the 
increased neurogenesis.  Untreated PACAP KO mice also have increased 
expression of Cox2 compared to WT, suggesting an increase in inflammatory 
responses in the OE.  However, no other inflammatory factor examined was 
different between untreated PACAP KO and WT mice.  After methimazole insult, 
PACAP KO mice had a greater decrease in protein levels of OMP compared to 
WT mice 24 hr later but had no differences in the decrease of Omp expression at 
this time.  The faster loss of OMP protein in PACAP KO mice supports the 
hypothesis that PACAP promotes survival in the OE.  Expression of Gap43 was 
greatly decreased after methimazole insult similarly in both PACAP KO and WT 
mice.  Levels of GAP43 protein were increased in both PACAP KO and WT mice 
at 2 weeks after insult, indicating PACAP is not required in the regenerative 
capabilities of the OE.  However, Mash1 expression is elevated in PACAP KO 
mice compared to WT at 72 hr after injury and supports that PACAP KO mice 
have an earlier initiation of regeneration after damage compared to WT mice.  
Although PACAP seems to be regulating survival, the increase in pro-apoptotic 
Bax expression were similar between PACAP KO and WT mice at 24 hr; 
however, by 72 hr, Bax expression, although still elevated, was already 
decreasing in PACAP KO mice. 
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 Methimazole-induced changes in expression of inflammatory factors were 
compared between PACAP KO and WT mice.  Inflammatory responses are 
important for OSN turnover.  Bulbectomy-induced apoptosis of OSNs results in 
increased levels of MIP-1α, which in turn increases recruitment of macrophages 
to the OE (Getchell et al., 2002a; Getchell et al., 2002b; Kwong et al., 2004).  In 
vivo studies indicate the importance of the inflammatory response in OE damage 
and repair (Borders et al., 2007a; Getchell et al., 2006).  PACAP may influence 
the inflammatory response involved in OSN turnover.  PACAP has been shown 
to inhibit production of pro-inflammatory chemokines such as MIP-1α, TNFα, and 
IL-6 (Delgado et al., 1999; Delgado et al., 2002; Delgado et al., 2003b).  
Additionally, an in vivo study demonstrated an anti-inflammatory effect of 
intranasal administration of PACAP in mice with ovalbumin-induced asthma 
(Lauenstein et al., 2011) and that PACAP KO mice have an increase in pro-
inflammatory cytokine expression after facial nerve injury (Armstrong et al., 
2008).  Therefore, we examined methimazole-induced changes in expression 
levels of Ccl3, Il6, Tnfα, Cox2, and Iba1 in the OE between PACAP KO and WT 
mice.  At 4 hr after insult, the PACAP KO mice have increased expression in all 
factors except Iba1 compared to WT mice.  However, the PACAP KO mice have 
higher expression of Iba1 at 24 hr after insult compared to WT mice.  Expression 
of Cox2 is increased in untreated PACAP KO mice compared to WT mice, and 
still has larger increases than WT mice at 4 and 72 hr after methimazole injury.  
The increase in expression of inflammatory factors, resulting from injury, in the 
PACAP KO mice suggest that PACAP has an anti-inflammatory effect in the 
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adult OE.  This increase in inflammation in the PACAP KO OE could lead to 
increased apoptosis.  Although we did not see a difference in the change of 
expression for pro-apoptotic factor, Bax, an increase in OSN cell death would 
result in the increased or primed regenerative state of the OE in 
PACAP KO mice. 
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Figure 3.1.  Comparison of OE morphology between WT and PACAP KO mice 
before and after methimazole treatment.  Coronal sections of WT (upper panels) 
and PACAP KO (lower panels) OE before, 24 hr, 72 hr, and 2 weeks after 50 
mg/kg methimazole treatment.  At 24 hr, the OE is more degenerated in the 
PACAP KO mouse.  At 72 hr, the PACAP KO OE is a few cells thick but 
disorganized compared to the WT mouse.  At 2 weeks postinjection, both the WT 
and PACAP KO OE are starting to recover.  Although it is not at pre-injection 

















   
   
   




   
   
   
   
   
   




   
   
   
   




















Figure 3.2.  Assessment of olfactory function in WT and PACAP KO mice after 
methimazole insult.  At 24 hr after insult, the PACAP KO mice (solid bars) could 
not locate the malt ball within a 5 min trial.  The WT mice (open bars) were 
impaired compared to pre-injection time, but located the malt ball significantly 
faster than PACAP KO mice.  At 48 hr after insult, the WT mice could not locate 
the malt ball within a 5 min trial.  However, the PACAP KO mice regained the 
ability to find the malt ball, although they were slower compared to pre-injection 
times.  At 72 hr postinsult, the WT mice began to recover the ability to find the 
malt ball; however, they were significantly slower than PACAP KO mice.  At 1 
week after insult, the WT and PACAP KO mice showed similar performance 
abilities, both of which were slower than pre-insult times.  At 2 weeks after insult, 
both the WT and PACAP KO mice were able to locate the malt ball at times 


































Figure 3.3.  Comparison of protein levels between WT and PACAP KO mice 
before and after methimazole insult.   (A) Representative WB for OMP, GAP43, 
Iba1, and Actin.  Lanes; 1: pre-insult, 2: 4 hr, 3: 24 hr, 4: 72 hr, 5: 1 wk, 6: 2 wk.  
(B) Quantification of OMP WB band density in WT (open bars) and PACAP KO 
(solid bars) mice.  After methimazole insult, the levels of OMP protein decrease 
in both WT and PACAP KO mice until 72 hr and then start to increase.  At 2 
weeks, OMP levels are increasing but below pre-insult levels.  However, the 
PACAP KO mice have a greater decline in OMP by 4 hr compared to WT mice.  
(C) Quantification of GAP43 WB band density.  After methimazole insult, the 
levels of GAP43 slightly decline and then begin to rise at 72 hr postinsult in the 
PACAP KO mouse and at 1 week in WT mice.  (D) Quantification of Iba1 WB 
band density.  Protein levels increase after insult until 24 hr, by 72 hr it decreases 
to very low levels, and stays low as long as 2 weeks later in both WT and PACAP 
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Figure 3.4.  Comparison of mRNA expression in WT and PACAP KO mice before 
and after methimazole insult.  (A) Fold changes in gene expression in OE of 
PACAP KO compared to WT mice before methimazole insult.  Although no 
significant differences in expression levels were found between WT and PACAP 
KO mice, the expression levels of Omp, Gap43, Mash1, and Cox2 were greater 
than the 90%-95% CI in PACAP KO mice compared to WT.  (B-J) Fold changes 
in mRNA expression at 4, 24, and 72 hr after methimazole insult for each 
genotype compared to the untreated levels of the same genotype.  Expression 
levels are shown for Omp (B), Gap43 (C), Mash1 (D), Bax (E), Iba1 (F), Ccl3 (G), 
Il6 (H), Tnfα (I) (inset shows difference between PACAP KO and WT mice at 4 hr 
postinsult) and Cox2 (J).  # PACAP KO average falls outside the 95% CI of WT 
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Table 3.1.  List of forward and reverse primers used for qRT-PCR 
     
Omp 
5'- GGCACCTCGCAGAACTGGA -3' Forward 
5’- GTCTGCCTCATTCCAATCCAT -3’ Reverse 
     
Gap43 
5’- GCTGTATGAGAAGAACCAAACA -3’ Forward 
5’- GTGTCCACGGAAGCTAGCCT -3’ Reverse 
     
Mash1 
5’- CTCTCCTGGGAATGGACTTTG -3’ Forward 
5’- AGGTTGGCTGTCTGGTTTG -3’ Reverse 
     
Bax 
5'- TTGGAGATGAACTGGACAGC -3’ Forward 
5’- CAGTTGAAGTTGCCATCAGC -3’ Reverse 
     
Iba1 
5’- CGATGATCCCAAATACAGCAATG -3’ Forward 
5’- CCCAAGTTTCTCCAGCATTC -3’ Reverse 
     
Ccl3 
5’- GATTCCACGCCAATTCATCG -3’ Forward 
5’- TTCAGTTCCAGGTCAGTGATG -3’ Reverse 
     
Il6 
5’- GATGCTACCAAACTGGATATAATCA -3’ Forward 
5’- CTCTGAAGGACTCTGGCTTTG -3’ Reverse 
     
Tnfα 
5'- ACCCTCACACTCAGATCATCTTCT -3' Forward 
5'- TGCTACGACGTGGGCTACAG -3' Reverse 
     
Cox2 
5’- CTCACGAAGGAACTCAGCAC -3’ Forward 
5’- GGATTGGAACAGCAAGGATTT -3’ Reverse 
     
Beta Actin 5’- GCTGTATTCCCCTCCATCG -3’ Forward 











Summary and Discussion 
 We studied the role of pituitary adenylate cyclase-activating polypeptide 
(PACAP) in developmental and adult olfactory epithelium (OE) neurogenesis in 
vivo.  Levels of proliferation, numbers of total and neuronal cells, and epithelial 
thickness were compared between PACAP knock-out (KO) and wild-type (WT) 
mice at neonatal and adult ages.  Comparisons of adult PACAP KO and WT 
mice olfactory function, and insult-induced regeneration were made with 
histology, Western blot, qRT-PCR, and behavioral assays. 
 
In vivo effects of PACAP on neonatal mice 
 We assessed the effects of PACAP on OE development using neonatal 
P3 PACAP KO and WT mice.  At age postnatal 3 (P3), PACAP KO mice have 
reduced levels of proliferation compared to WT mice.  In correlation with 
decreased proliferation, PACAP KO mice have significantly decreased levels in 
the percentage of GAP43 labeling, indicating a decrease in immature olfactory 
sensory neurons (OSNs), compared to WT mice.  These data are consistent with 
in vitro studies showing addition of PACAP to primary OSN cultures results in 
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increased proliferation and number of immature OSNs (Hansel et al., 2001).  
However, there was no significant difference in the number of mature OSNs 
between PACAP KO and WT mice.  Epithelial thickness and total cell counts 
were also similar between PACAP KO and WT mice.  Our results indicate that 
PACAP is not required for maturation of OSNs, but is required for normal levels 
of proliferation in early neonatal OE. 
 We also compared neurogenesis between PACAP KO and WT mice at 
age P7, when the OE is transitioning from a developmental to a more mature 
state.  At this age, we observed no significant differences between PACAP KO 
and WT mice.  Unlike P3 PACAP KO mice, P7 PACAP KO mice had normal 
levels of proliferation and GAP43 staining.  The change in effects seen in PACAP 
KO mice at P3 and P7 could be a result of PACAP expression changes in the 
OE.  It has been shown that PACAP is located in the OSN nerve bundle in P4 
mice but is found throughout the OE in adult mice (Hegg et al., 2003).  Here our 
studies indicate that PACAP is no longer required to maintain normal levels of 
proliferation in the OE by P7, suggesting PACAP may have different roles at 
different ages or developmental stages. 
 
In vivo effects of PACAP on adult mice 
 To further investigate the role of PACAP in the OE, we compared 
maintenance of P64 OE between PACAP KO and WT mice.  The PACAP KO 
mice had significantly thinner OE compared to WT mice, suggesting that PACAP 
is required in the maintenance or turnover of the OE.  Surprisingly, PACAP KO 
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mice had increased proliferation compared to WT mice.  These data suggest that 
PACAP may inhibit proliferation at later ages.  However, this is unlikely given that 
the decrease in thickness of OE was due to decreased total number of cells in 
PACAP KO mice compared to WT mice.  The increase in proliferation but a loss 
of cells implies increased cell death in the PACAP KO mice compared to WT 
mice.  The largest decrease in thickness in PACAP KO mice was seen in the 
basal third of the OE, indicating increased apoptosis in immature OSNs.  It has 
been shown that although apoptosis occurs throughout the OE, most cell death is 
seen in the immature OSNs (Mahalik, 1996; Kondo et al., 2010).  Due to the 
inherent regenerative capabilities of the OE, an increase in apoptosis in PACAP 
KO OE could lead to the observed increase in proliferation.  We found that 
expression levels for Mash1, Gap43, and Omp are increased in adult PACAP KO 
mice compared to WT mice, indicating increased turnover in the OE.  However, 
no difference in the number of OMP positive OSNs was detected between 
PACAP KO and WT mice.  The phenomenon of having decreased OE cell 
numbers and height but the normal number of OSNs has been reported in aging 
mice OE (Kondo et al., 2010).  Additionally, PACAP KO mice had normal 
olfactory function in detecting and locating food odors compared to WT mice.  
The compromised OE in PACAP KO mice suggests PACAP influences survival, 






In vivo role for PACAP during OE degeneration  
and regeneration 
 To further investigate the role of PACAP in survival of OE, we compared 
insult-induced degeneration and regeneration of OE between adult PACAP KO 
and WT mice.  We used the antithyroid drug, methimazole, to induce injury and 
apoptosis of the OE (Bergman and Brittebo, 1999; Sakamoto et al., 2007; 
Suzukawa et al., 2011; Xie et al., 2011). Through the use of histological, Western 
blot, and behavioral testing, we showed that the PACAP KO mice have a faster 
disruption of the OE and onset of anosmia compared to WT mice.  In addition, 
PACAP KO mice also have a faster initial regeneration of the OE compared to 
WT mice; however, these differences disappear by 2 weeks postinsult.  The 
accelerated regeneration seen in PACAP KO mice is probably due to the 
increase in proliferation seen in untreated PACAP KO animals where the OE is 
already primed to recover from a larger insult.  The recovery of the PACAP KO 
OE also suggests that PACAP is not required for adult proliferation.  However, 
the faster degeneration of PACAP KO OE implicates PACAP’s influence on 
survival. 
 Differences in the inflammatory response were examined between PACAP 
KO and WT mice before and after methimazole treatment.  Changes in 
expression levels of inflammatory factors were measured with qRT-PCR.  The 
inflammatory response is important in regeneration of the OE in response to 
injury, such as bulbectomy (Getchell et al., 2006; Borders et al., 2007).  
Untreated PACAP KO mice have elevated expression of Cox2 compared to 
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untreated WT mice, suggesting an increase in basal inflammatory responses in 
PACAP KO mice.  Increased inflammation could lead to increased cell death in 
the OE.  The PACAP KO mice had a larger inflammatory response 4 hr after 
methimazole treatment compared to WT mice as demonstrated by greater 
increases in expression of the pro-inflammatory factors, Ccl3, Il6, Tnfα, and 
Cox2.  The faster degeneration of the OE resulting from methimazole insult in 
PACAP KO mice could be due to a larger inflammatory response.  These data 
suggest that PACAP promotes survival of OSNs by regulating inflammatory 
responses. 
 This study is the first to investigate, in vivo, the role of PACAP in the OE.  
We show an age-dependent change in the role of PACAP.  PACAP promotes 
proliferation in early neonatal mice OE, but does not have an affect at an age of 1 
week.  However, in adults, PACAP is suggested to play a role in survival of 
OSNs possibly through regulation of inflammatory responses. 
 
Limitations and Future Directions 
 Although this study provides a characterization of PACAP function in the 
OE, many questions still remain.  First, one limitation of this study was the 
number of PACAP KO animals available.  The initial examination of P64 OE 
included PACAP KO tissue obtained form Dr. Washeck.  However, additional 
tests characterizing proliferation and OSN numbers are being done on PACAP 
KO mice from our colony.  In addition, the number of animals used for Western 
blots and q-RT-PCR needs to be increased.  A larger sample size will be useful 
  
98 
in determining the normal variance between mice within a genotype.  This will 
also allow statistical analysis of the data and better illustrate significant 
differences between PACAP KO and WT mice. 
 Second, our study implicates increased apoptosis in adult PACAP KO OE, 
but we were unable to measure apoptosis directly.  Attempted detection of 
apoptotic cells in the OE with TUNEL labeling gave inconsistent results.  Instead, 
to measure apoptosis, we will label for and count caspase-3 positive cells in the 
OE of PACAP KO and WT mice.  This will also help confirm which cell types are 
apoptotic, given that our data suggest the immature OSNs have decreased 
survival in PACAP KO mice. 
 Third, we show that PACAP KO mice have normal food odor detection.  
However, we did not examine function in detection of olfactory cues regulating 
social and gender behaviors.  Impairments in processing olfactory social cues 
can lead to abnormal mating and aggression (Nicot et al., 2004).  We will 
investigate differences between PACAP KO and WT mice in multiple social 
behaviors.  Experiments will look at the time, over repeated presentations, male 
PACAP KO and WT mice spend investigating a female or urine from a female.  
Aggression toward intruder males will also be examined.  These studies will 
provide a more complete understanding of PACAP in olfactory function. 
 Furthermore, additional experiments examining survival and inflammation 
in adult OE will be performed.  Intranasal administration of PACAP will be done 
to establish whether the decreased OE thickness, and increased apoptosis can 
be rescued in the PACAP KO mouse.  If rescue is possible with PACAP, 
  
99 
intranasal administration of maxadilan will determine if the rescue effects are 
mediated through the PAC1 receptor.  In addition, administration of an anti-
inflammatory drug before methimazole treatment will help determine if the faster 
loss of OE in PACAP KO mice is due to the observed increase in inflammation. 
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THE PRENYL BINDING PROTEIN PrBP/δ ENABLES  





 In mouse photoreceptors, the prenyl binding protein PrBP/δ is required for 
normal transport of phosphodiesterase 6 (PDE6) and rhodopsin kinase (GRK1), 
and the acyl-binding protein UNC119 regulates the return of transducin to the 
photosensitive cilia after photobleaching.  Here we investigated whether these 
ubiquitous lipid binding proteins may also play a role in transport of peripheral 
membrane proteins in olfactory sensory neurons (OSNs).  Behavioral tests 
showed that Pde6d-/- and Unc119-/-  mice were capable of discriminating between 
the odorants R and S carvone, although the investigation time was reduced in 
Pde6d-/- mice. Pde6d-/- electro-olfactogram (EOG) peak amplitudes in response to 
various odorants were only 23 ± 10% of control EOG responses, indicating that 
Pde6d-/- mice are dysosmic.  We investigated the distribution of Golf subunits and 
found a dramatic decrease in immunoreactivity for Golfα and Gγ13 in the cilia of 
Pde6d-/- OSNs, but normal localization of adenylate cyclase III (ACIII) and the 
olfactory cyclic nucleotide-gated channel subunit A2 (CNGA2). Deletion of 
UNC119 had no effect on localization of Golfα or Gγ13.  Pulldown studies showed 
tight association between PrBP/δ and the prenylated Gγ13 subunit.  EOG 
responses evoked by forskolin, bypassing olfactory receptors, were similar in 
wild-type and Pde6d-/- mice consistent with a defect upstream of ACIII.  
Collectively, our studies suggest that PrBP/δ, but not UNC119, plays a role in 
trafficking of heterotrimeric Golf to the cilia of mouse OSNs and is required for 





 The olfactory system is composed of a number of distinct subsystems that 
can be distinguished by the location of their sensory neurons, their specific 
receptors, and their signaling pathways (Munger et al., 2009; Kaupp, 2010).  In 
the canonical olfactory transduction pathway (Buck and Axel, 1991; Reed, 1992; 
Ache and Young, 2005), the binding of an odorant molecule to an odorant 
receptor (OR) activates the olfactory heterotrimeric G-protein comprised of Golfα 
(Jones and Reed, 1989), Gβ1 (Kerr et al., 2008) and Gγ13 (Kulaga et al., 2004).  
In contrast to phototransduction, one odorant-bound OR activates one Golf 
providing no amplification at the G protein step of the transduction cascade (Ben-
Chaim et al., 2011).  Golfα activation of adenylate cyclase III (ACIII) (Bakalyar and 
Reed, 1990) increases levels of cAMP, thereby opening CNG channels 
consisting of two CNGA2, one CNGA4, and one CNGB1b subunit (Bonigk et al., 
1999).  The resulting Ca2+ influx depolarizes the membrane and activates 
additional Ca2+- and voltage-gated channels (Ronnett and Moon, 2002).  
 The detection of odor signals relies on correct trafficking of odorant 
receptors and transduction proteins to the cilia.  The components involved in 
olfactory signal transduction are membrane proteins, either integral (ORs, ACIII, 
and CNG channels) or peripherally associated (Golfα, Gβ1γ13).  Golfα is predicted 
to be N-acylated at its N-terminal Gly (G2) and S-palmitoylated at C3, whereas 
Gγ13, forming a tight complex with Gβ1, is predicted to be geranylgeranylated at 
its C-terminal cysteine (Schwindinger and Robishaw, 2001; Linder and 
Deschenes, 2007; Marrari et al., 2007).  These posttranslational processing 
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steps are essential for membrane association, protein-protein interactions, and 
trafficking (Magee and Seabra, 2005; Jenkins et al., 2009; Kizhatil et al., 2009).  
The heterotrimeric Golf is most likely assembled at the cytoplasmic face of the 
endoplasmic reticulum (ER) in the soma of olfactory neurons.  It traffics to the 
proximal cilia (basal bodies) by unknown mechanisms.  
 PrBP/δ (encoded by the Pde6d gene) is required for transport of a subset 
of prenylated proteins to photoreceptor cilia (Zhang et al., 2007).  PrBP/δ 
associates with prenylated proteins by inserting their prenyl anchors into a 
hydrophobic pocket formed by a immunoglobulin-like β-sandwich fold (Hanzal-
Bayer et al., 2002).  This interaction regulates stability and transport to the outer 
segments of several prenylated proteins, including GRK1 and phosphodiesterase 
(PDE) subunits ( Zhang et al., 2007).  Deletion of the Pde6d gene resulted in 
disrupted trafficking of GRK1 and PDE to the outer segments, but did not 
significantly affect transducin subunits.  We recently identified UNC119, which 
shares structural similarity with PrBP/δ, as an acyl-binding protein with specificity 
for the acylated N-terminus of the transducin α-subunit (Tα) as well as other G 
protein α-subunits, specifically ODR-3 and GPA-13 in C. elegans olfactory 
neurons (Zhang et al., 2011).  
 UNC119 deletion leads to photoreceptor degeneration in mouse (Ishiba et 
al., 2007) and deficiencies in chemosensation in C. elegans (Maduro and Pilgrim, 
1995).  Furthermore, we previously noted that Pde6d-/- mice had reduced body 
weight in the first month of life and suspected dysosmia (impaired sense of smell) 
to occur in these mutants.  We therefore investigated the consequences of 
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PrBP/δ and UNC119 deletion on transport of Golf in mouse olfactory neurons, 
assuming that disruptions of Golf trafficking may lead to impaired or loss of ability 
to smell (Brunet et al., 1996; Belluscio et al., 1998; Zufall and Munger, 2001; 
Kulaga et al., 2004; Jenkins et al., 2009).  We show that in the Unc119-/- mice, 
Golfα trafficked normally to the cilia and olfaction was largely normal.  In Pde6d-/- 
OSNs, in contrast, Golfα mislocalized and electrical responses to odorants were 
significantly reduced compared to age-matched control mice.  EOG responses 
evoked by forskolin, bypassing olfactory receptors, were similar in wild-type and 
Pde6d-/- mice consistent with a defect upstream of ACIII at Golf.  Our studies 
suggest that PrBP/δ plays a role in trafficking of heterotrimeric Golf to the cilia of 





 Four PDE6d-/- (SV129/C57BL mixed background), 4 Unc119-/-, and 12 WT 
mice (C57BL) between 7 weeks to 28 months old were used for behavioral 
experiments.  All animal procedures were approved by the University of Utah 
Institutional Animal Care and Use Committee and were conducted under the 







 The ability of mice to discriminate a second novel odorant (odor 2) 
following habituation to a first repeated odorant (odor 1) was tested.  A 10 mm 
diameter disk of filter paper was placed into a 1 ml pipette tip and 6 µl of pure 
odorant was applied to the filter paper.  Mice were removed from the home cage 
and placed in a clean testing cage for 30 min. The odor was introduced by 
attaching the pipette tip to the top of the cage and the time of active investigative 
sniffing was recorded.  There were a total of 5 odor presentations or trials, each 
lasting 2 min with 1 min between presentations.  R-carvone was used for the first 
3 and last presentations, whereas the enantiomer S-carvone was the novel odor 
used for the fourth trial.  Investigation time was compared between WT and 
Pde6d-/- or Unc119-/- mice for each odorant trial using unpaired Student’s t-test 
(p<0.05).  
 
Preparation for EOG 
 Mice were anesthetized with CO2, followed by cervical dislocation and 
decapitation.  The EOG recordings were performed on a subset of the 
behaviorally tested mice: 3 each of Pde6d-/- and Unc119-/- mice, as well as their 
respective age-matched WT control mice (n = 3 each, 6 total).  The lower jaw 
and skin were removed and the skull was hemi-sectioned along the midsagittal 
plane.  The left half of each skull was immediately immersion fixed and used for 
immunocytochemistry.  The other half with turbinates exposed was secured on a 
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stereomicroscope stage and maintained in a constant low-pressure 34°C 
humidified stream of air. 
 
EOG recording 
 The glass recording electrode (~1 µm tip) was filled with Ringer’s solution 
(140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM HEPES, 10 mM 
glucose) and recordings were made at 3 locations on the exposed turbinates 
using a stereomicroscope.  The ground electrode was a silver chlorided wire 
inserted into a 3 M KCl agar bridge and placed just inside the skull.  EOG 
responses were acquired at a sampling rate of 5 ms and filtered at 200 Hz using 
Axoscope 7.0 software, an Axoclamp 200B, and Digidata 1340 interface. 
Odorants (15 µl) were applied to a pipette filter and introduced into the humidified 
air stream using a picospritzer.  The picospritzer durations were adjusted to 
generate approximately the same peak amplitudes for the 3 odorants: 2-
heptanone (200 ms), n-amyl acetate (500 ms), and (-)-menthone (1 sec).  Each 
odorant was applied twice at 2 min intervals except for the menthone application 
which had a 4-5 min interval.  Following odorant testing, a water control was 
applied through the same setup.  Stock solutions of forskolin (10 mM), to directly 
stimulate ACIII and IBMX (50 mM), to inhibit the breakdown of ACIII, were made 
up in EtOH and diluted to create a working concentration of 100 µM forskolin and 
1 mM IBMX (F/I) in water.  The F/I mixture and water controls were applied using 




EOG data analysis 
 Axoscope 7.0 software was used to determine the amplitude in mV of the 
EOG responses.  Initial analysis indicated that the EOG amplitudes were not 
significantly different at the 3 different recording sites within the same animal.  
Thus, the peak amplitudes of all 3 recording sites were recorded for each mouse 
and averaged across all mice according to odorant and genotype.  The 
experimenter was blind to genotype when making the recordings and 
measurements.  Statistical analyses included unpaired Student’s t-tests (p<0.01) 
of the EOG responses in WT versus Pde6d-/-, WT versus Unc119-/-, overall 
odorant responses versus water controls (p<0.01), and WT and Pde6d-/- F/I 
versus water controls (p<0.05).  
 
Immunocytochemistry 
 The hemisection of the mouse head was immersion-fixed in 4% 
paraformaldehyde for 2 hr at 4°C followed by decalcifying (Rapid decalcifier, 
Apex Engineering Products Corp. Plainfield, IL) for 4 hr at room temperature.  
For cryoprotection, the tissue was incubated in 30% sucrose in PBS overnight at 
4°C.  The tissue was embedded in OCT and 12 µm thick sections were cut.  For 
immunostaining, the sections were blocked in PBS buffer containing 10% goat 
serum, 1% BSA, 0.1% Triton X-100 for 1 h at room temperature in a humidified, 
rotating chamber.  Primary antibodies were applied to the sections overnight at 
4°C. FITC or TRIC-conjugated secondary antibodies (1:300; Jackson Immuno 
Research Laboratory) were incubated with the sections for 1 hr at room 
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temperature.  Zero primary and secondary controls were used to confirm 
specificity.  The images of the sections were acquired by a Zeiss LSM510 
confocal microscope.  The dilutions for the primary antibodies were 1:100 for 
anti-Golfα (Santa Cruz Biotechnology), 1:200 for anti-ACIII (Santa Cruz 
Biotechnology), 1:100 for anti-Gγ13 (gift from Dr. R. Margolskee, Mount Sinai 
School of Medicine of New York University), 1:100 for anti-CNGA2 (Alomone 
Labs) and 1:1,000 for anti-acetylated tubulin (Sigma–Aldrich).  
 
Pulldown assay 
 GST-PrBP/δ was expressed and purified as described previously (Zhang 
et al., 2004).  Olfactory tissue from 3 wild-type mice was homogenized by brief 
sonication in 1 ml PBS buffer with 1mM DTT and 10 µl protease inhibitor cocktail 
(Roche).  The insoluble debris was removed by centrifugation at 8,000g for 10 
min.  Pulldown assays were performed as previously described (Zhang et al., 
2011).  Western blots were probed with polyclonal anti- Gγ13 (1:150; sc-26782, 
Santa Cruz Biotechnology).  The signal was visualized by ECL 
(enhanced chemiluminescence) kit (Perkin Elmer). 
 
Results 
Altered behavioral responses to odorants in Pde6d-/-  
and Unc119-/- mice 
 We first investigated olfactory function in Pde6d-/- and Unc119-/- mice 
using an odor habituation behavioral paradigm.  In experiments involving 3 
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repeated exposures to an odorant, the animals are expected to habituate and 
spend less time investigating the odor source with each presentation.  When a 
novel second odorant is presented on the fourth trial, the time that the animals 
spend investigating the source should increase if they can detect a difference 
from the first odorant.  Using R-carvone as the first odorant, WT and mutant 
groups showed relatively normal habituation (Fig. A.1).  However, Pde6d-/- mice 
exhibited significantly shorter investigation times than WT mice for the first 
(p=0.047) and second (p=0.04) odor presentations (indicated by *) suggesting 
reduced odor sensitivity.  Even though the Unc119-/- mice habituated to R-
carvone, they had significantly longer investigation time than WT at the third 
presentation (indicated by #, p=0.024).  The increased investigation times by WT 
and both sets of mutant mice in response to odorant 2 (S-carvone) showed that 
all groups could identify odorant 2 as novel.  
 
Olfactory function is reduced in mice lacking PrBP/δ,  
but not in mice lacking UNC119 
 Olfactory function was also assessed at the level of the olfactory 
epithelium (OE) using EOG recordings which measure the electrical field 
potential responses of OSNs to odor stimuli (for review see Scott and Scott-
Johnson, 2002).  Three different odorants (2-heptanone, n-amyl acetate, and (-)-
menthone) together with water as a control were tested on OE from litter-mate or 
age matched WT, Pde6d-/-, and Unc119-/- mice.  The Pde6d-/- mice had 
significantly reduced EOG amplitudes that were 21-25% of the average WT 
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responses (Fig. A.2A, Student’s t-test; P < 0.01), while Unc119-/- EOG responses 
resembled WT responses (Fig. A.2B; P>0.05).  Collectively, these results 
indicate that Pde6d-/- mice have impaired peripheral olfactory function and are 
dysosmic. 
 
Localization of Gγ13 and Gαolf in WT and mutant in  
olfactory cilia 
 Based on their ubiquitous occurrence and their ability to interact with 
lipids, absence of PrBP/δ and UNC119 could affect trafficking of Golf to OE.  We 
therefore investigated the localization of Golf subunits in WT, Pde6d-/-, and 
Unc119-/- olfactory epithelia by immunocytochemistry.  We found that prenylated 
Gγ13 was undetectable and acylated Golfα was at reduced levels in Pde6d-/-, but 
present at WT levels in Unc119-/- OSNs (Fig. A.3A).  Reduction of Golf levels in 
Pde6d-/- olfactory cilia predicts decreased olfactory responses, in agreement with 
habituation and EOG experiments (Figs. A.1,A.2).  Interestingly, PrBP/δ deletion 
in mouse did not affect the localization of transducin γ-subunit (Tγ) in retinal 
photoreceptors (Zhang et al., 2007), but deletion of UNC119 affected transport of 
Tα in rods after light induced translocation (Zhang et al., 2011).  The reasons for 
these differential specificities are unclear.  
 The results in Fig. A.3 predict a strong interaction of PrBP/δ with Gγ13 at 
the level of biosynthesis, or a role of PrBP/δ as a chaperone in Gγ13 trafficking to 
the olfactory cilia (see discussion).  To test the interaction of PrBP/δ with Gγ13, 
we used the glutathione S-transferase (GST) pulldown technique with GST-
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PrBP/δ as a bait.  The result indicated that GST- PrBP/δ, but not a GST control, 
could pulldown Gγ13, suggesting that interaction is mediated by the 
geranylgeranyl group attached to its C-terminus (Fig. A.3B).  
 Pulldowns of Golfα with GST-UNC119 were negative (results not shown).  
Absence of a Golf trafficking defect in Unc119-/- OSNs was unexpected as Golfα is 
predicted to be N-myristoylated (C14 chain) at glycine 2 (G2), the site of 
interaction Gα subunits with UNC119 (Zhang et al., 2011).  However, it has 
recently been observed that Gαs, which is closely related to Golfα and with which 
it shares an identical N-terminal sequence (MGCLGNSSKT), is N-palmitoylated 
(C16 side chain) (Kleuss and Krause, 2003).  Thus it is likely that Golfα may be N-
palmitoylated as well and that a C16 chain maybe too bulky to fit into the 
hydrophobic cavity of UNC119, providing an explanation for pulldown failure. 
 
The Pde6d-/- olfactory transduction pathway is  
functional beyond the G-protein step 
 To test the functionality of the olfactory transduction pathway downstream 
of Golf in Pde6d-/- mice, EOGs were recorded using forskolin to bypass the ORs 
and directly activate ACIII.  The results show that Pde6d-/- mice had similar EOGs 
in response to forskolin compared to wild-type (Fig. A.4A, B; n= 4; p>0.05), 
consistent with the notion that the defect in olfactory function in Pde6d-/- mice is 
upstream of ACIII.  To test for normal presence of downstream components ACIII 
and CNGA2, we specifically labeled cilia of WT and Pde6d-/- OSNs with anti-
acetylated α-tubulin (red, Fig. A.5, middle panels) and double labeled with 
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antibodies against either ACIII or CNGA2 (green, Fig. A.5, left panels).  As 
expected, immunostaining showed that in contrast to the absence of targeting of 
Golfα and Gγ13 to Pde6d-/- olfactory cilia (Fig. A.3A), the downstream effector 
proteins ACIII and CNGA2 showed normal co-localization with acetylated α-
tubulin (Fig. A.5B, D, right panels).  These results indicate that the olfactory 
deficits that we observed in Pde6d-/- mice are a consequence of defective 
transport of G proteins to OSN cilia.  
 
Discussion 
 In this communication we investigated trafficking of Golf in Pde6d-/- and 
Unc119-/- olfactory cilia.  Behavioral and EOG recordings revealed that the 
Pde6d-/- mouse is dysosmic, suggesting mistrafficking of Golf, the only lipidated 
peripheral membrane protein in the olfactory cascade (GRK3, involved in 
phosphorylation of ORs and OR signal termination, is not prenylated (Onorato et 
al., 1995)).  Our main findings are: (i) the odorant investigation times and the 
peak amplitudes of odorant stimulated EOGs recorded from nasal turbinates are 
reduced in Pde6d-/- mice compared with age-matched or littermate controls; (ii) 
Golf subunits traffic normally to the cilia in Unc119-/- OSNs, while trafficking of 
Golfα and Gγ13 to the cilia is impeded in Pde6d-/- OSNs; (iii) GST-PrBP/δ pulls 
down Gγ13 in a GST binding assay; (iv) EOG responses evoked by forskolin, 
bypassing olfactory receptors/Golf and directly activating ACIII, were unaffected in 
Pde6d-/- mice consistent with a defect upstream of ACIII; (v) consistent with (iv), 
the labeling of OSN cilia in WT and Pde6d-/- with antibodies against either ACIII 
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or CNGA2 showed normal localization of these downstream transduction 
components of Golf. 
 Mechanisms regarding trafficking and ciliary targeting of heterotrimeric G 
proteins in sensory neurons are largely unknown.  Most of the details concerning 
G protein trafficking and assembly of GPCR-signaling complexes for trafficking to 
the plasma membrane (PM) are based on transfection of recombinant constructs 
in tissue culture (HEK293 cells, yeast) (for review, see Marrari et al., 2007).  In 
the canonical model, Gα subunits carrying the myristoylation consensus 
sequence (Farazi et al., 2001) are cotranslationally acylated, and Gβ and Gγ 
subunits combine following biosynthesis before or after prenylation of Gγ. Gβγ 
then dock to the ER for processing.  At the ER, the prenylated C-termini of Gγ13 
(prenyl-CAAX) are modified by removal of the three penultimate amino acids 
(AAX) and carboxymethylation of the C-terminal Cys (Hannoush and Sun, 2010).  
There is general agreement that Gαβγ heterotrimer formation is essential for 
plasma membrane (PM) targeting (Marrari et al., 2007).  It is unclear, however, 
where in the cell Gα and Gβγ interact, and how the complex traffics to the PM or 
to cilia in polarized neurons.  When Gαs and Gβγ were overexpressed in HEK 
cells, they targeted to the PM independent of the Golgi.  However, when a GPCR 
was co-expressed, PM targeting was Golgi dependent, and both GPCR and G 
protein followed the classic secretory pathway (Dupre and Hebert, 2006).  As 
ORs are likely in large excess over Golf, Golf is predicted to cotransport with ORs 
following the secretory pathway.  
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 Little is known about assembly of ACIII with Golf and OR receptors.  There 
is evidence that transmembrane AC dimers and GPCR dimers are the basic 
structural units that are assembled at the ER level (Cooper and Crossthwaite, 
2006; Palczewski, 2010).  It appears that entire signaling complexes including 
GPCRs, G protein, and target enzyme are assembled during biosynthesis, and 
prior to PM targeting (Dupre et al., 2007; Dupre et al., 2009).  One role of PrBP/δ 
may be involvement in assembly of heterotrimeric Golf at the ER level, or in 
assembly of the signaling complex consisting of ORs, Golf, and ACIII at a later 
stage (Fig. A.6).  
 An alternative pathway may be trafficking of G protein subunits by 
diffusion after formation of complexes with lipid binding proteins.  We showed 
recently that UNC119 can accommodate the C12- and C14-acyl side chains of 
transducin in a hydrophobic pocket, solubilizing the Tα subunit after GTP/GDP 
exchange and enabling its return to the rod outer segment by diffusion (Zhang et 
al., 2011).  However, a lipid binding protein that is able to accommodate palmitoyl 
(C16) side chains of Golfα has not been identified.  Similarly, Gγ13 may form a 
soluble complex with PrBP/δ enabling diffusion of Gβ1γ13 to cilia independently of 
Golfα.  In the absence of PrBP/δ, Gγ13 would remain ER-bound, unable to traffic 
to cilia and eventually be degraded. 
 Mistrafficking of Golfα in Pde6d-/- OSNs is in contrast to the effect of 
PrBP/δ deletion in photoreceptors, where trafficking of Tγ and Tα subunits 
proceeds mostly normally.  The main differences between Golf and transducin 
heterotrimers lie in the γ-subunits.  Gγ13 is widely expressed in the olfactory and 
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taste epithelia, olfactory bulb, brain (Huang et al., 1999), ON-bipolar cells (Ghosh 
et al., 2004) and mouse ovaries (Fujino et al., 2007).  Tγ (Gngt1) subunits are 
farnesylated (C15), whereas Gγ13 is geranylgeranylated (C20), but both have 
little (25%) sequence similarity to Gγ13.  Farnesyl moieties are more tightly 
associated with PrBP/δ than geranylgeranyl chains (KD of 0.7 µM and 19 µM, 
respectively) (Zhang et al., 2004).  Despite this 27-fold difference in favor of 
farnesyl, geranylgeranylated Gγ13 is pulled down by GST-PrBP/δ, and its 
trafficking is affected in Pde6d-/- OSNs, while rod Tγ is not pulled down and 
trafficking is largely unaffected.  As the C-terminal 10 residues of the γ-subunits 
are very similar (Fig. A.7), other domains located on Gγ13 may contribute to 
strengthen the interaction between Gγ13 and PrBP/δ.  
 The Pde6d-/- OSN phenotype essentially resembles a Golf knockdown.  
Consistent with a knockdown, we observed that Pde6d-/- EOG responses to 
odorants were significantly reduced, with peak amplitudes of the odorant 
responses approximately ranging from 21% to 25% of age-matched wild types.  
Similarly, in rod photoreceptors, genetic deletion of rod Tγ led to a major 
downregulation of Tβ and Tα, yet low levels of Tα present in mutant outer 
segments were sufficient to support phototransduction at reduced sensitivity 
(Lobanova et al., 2008).  The relatively mild phenotype of dysosmia seen in 
Pde6d-/- mice contrasts with that in adult Golfα knockouts, where EOG amplitudes 
in response to a variety of odors were essentially zero consistent with anosmia 
and failure to thrive (Belluscio et al., 1998).  The few Golfα knockout mice that do 
survive have reduced body weight and suffer competitive disadvantages for 
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feeding.  The phenotype of reduced body weight in Pde6d-/- mice is much less 
dramatic and the mutant mouse eventually recovers a normal body weight after 1 
month of age (Zhang et al., 2007).  It is conceivable that Pde6d-/- mice are unable 
to taste sweet and bitter substances, as gustducin and Golf share the Gγ13 
subunit, further contributing to the low body weight phenotype (Huang et al., 
1999).  
 Mutations in ciliary proteins often lead to malfunction in intraflagellar 
transport (IFT) and pleiotropic human diseases including Joubert syndrome, 
Meckel syndrome, Senior-Loken syndrome, Bardet-Biedl syndrome (BBS) and 
polycystic kidney disease (Otto et al., 2005; Badano et al., 2006; Sayer et al., 
2006; Valente et al., 2006; Baala et al., 2007).  An in-frame deletion in CEP290 
(NPHP5), a protein localized to the centrosome and cilia, is associated with 
Leber congenital amaurosis, a type of severe retinal degeneration characterized 
by visual impairment from birth (den Hollander et al., 2006; den Hollander et al., 
2008).  This mutation has also been linked to abnormal olfactory function in both 
humans and mice due to disrupted trafficking of olfactory signal transduction G-
proteins to the cilia (McEwen et al., 2007).  BBS proteins that are mutated in 
Bardet-Biedl syndrome are associated with basal bodies, centromeres, and 
microtubule transport (May-Simera et al., 2009).  Some patients with BBS are 
anosmic.  Also, Bbs1, Bbs4, and Bbs8 knock-out mice have reduced responses 
to odorants caused by impaired protein trafficking, including Gγ13 (Kulaga et al., 
2004) and ACIII as well as disrupted cilia structure (Kulaga et al., 2004; Tadenev 
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et al., 2011).  Although the human Pde6d gene has not yet been associated with 
a human olfactory or retinal dysfunction, our data suggest that patients lacking 
the Pde6d gene may be dysosmic, and develop a recessive cone-rod dystrophy.  
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Figure A.1. Odor presentations to WT, Pde6d-/- , and Unc119-/- mice in a 
habituation behavioral paradigm. Odor 1, R-carvone; odor 2, S-carvone. All 
groups showed normal habituation to R-carvone (trial 1 through trial 3). Pde6d-/- 
mice have significantly shorter investigation times than WT mice at trial 1 and 
trial 2 (p<0.05, indicated by *), the Unc119-/- mice had significantly longer 
investigation time than WT at trial 3 (p<0.05, indicated by #). WT and both mutant 
mice identified odorant 2 as novel (trial 4). Significance was determined by 
unpaired Student’s t-tests. The results show that Pde6d-/- mice are dysosmic and 



































Figure A.2. EOG responses to various odorants (2-heptanone, n-amyl acetate, (-
)-menthone) in WT and mutant mice. A, representative EOG traces from WT and 
Pde6d-/- mice in response to a water control and the odorants indicated. B, 
representative EOG traces from WT and Unc119-/- mice. Pde6d-/- mice are 
dysosmic while Unc119-/- mice have normal olfaction. Prolonged responses in the 
(-)-menthone traces (green) were occasionally observed in both WT and Pde6d-/- 
and are likely due to the longer 1 sec pulse used to generate a similar response 
amplitude to other odorants (see Methods).  C, average peak EOG responses to 
the 3 odorants and water controls are shown for both WT (open bars) and Pde6d-
/- mice (solid bars). For each odorant, Student’s t-tests were performed on the 
averaged peak EOG responses in knockouts compared to the averaged WT 
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Figure A.3. Defects in localization of Gγ13 and Gαolf in olfactory epithelia. A, WT, 
Pde6d-/- and Unc119-/- olfactory epithelium cryosections probed with polyclonal 
anti-Gγ13 and anti- Gαolf antibody. Gγ13 is localized to cilia in WT OSNs but is 
undetectable in Pde6d-/- cilia. Gαolf is localized to the cilia in WT and Unc119-/- 
mice, but is essentially absent from cilia of Pde6d-/- mice. B, direct interaction 
between PrBP/δ, the protein encoded by the Pde6d gene, and Gγ13. Mouse 
olfactory extract pulldowns with GST-PrBP/δ and GST as a control were 
identified with anti-Gγ13 antibody. Input, olfactory epithelium crude extract. 
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Figure A.4. Forskolin stimulation of ACIII. A, representative EOG traces before, 
during, and after 100 µM Forskolin + 1 mM IBMX (F/I) and H2O control are shown 
for WT and Pde6d-/- mice. B, average peak EOG responses to F/I and H2O 
control were not significantly different using a Student’s t-test p = 0.03; n = 3 WT 
and 3 Pde6d-/- mice. The results show that the signal cAMP transduction pathway 































































Figure A.5.  ACIII and CNGA2 in OSNs show proper targeting to OSN cilia. A,C, 
Confocal images of immunostainted (WT) and B,D, (Pde6d-/-) olfactory epithelium 
cryosections. Cilia are identified by the acetylated α-tubulin immunoreactivity 
(red). ACIII and CNGA2 (green) are located in cilia and co-localize with 




























Figure A.6. Cartoon of Golf trafficking in OSNs. A, wild-type trafficking of 
membrane proteins. Prenylated Gγ13 and acylated Gαolf dock at the endoplasmic 
reticulum (ER), solubilize with the help of lipid binding proteins, and combine with 
a signaling complex carrying TM proteins (ACIII and CNGA2) to be trafficked to 
the olfactory cilia. B, Pde6d knockout. In the absence of PrBP/δ, Gβ1γ13 remains 
in the ER and Gαolf becomes soluble in the cytoplasm, but is unable to target 
efficiently to cilia. The signaling complex lacking Golf subunits, but containing 
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Figure A.7. The C-terminal regions of rod, cone, and olfactory Gγ subunits. The 
last 21 residues of rod Tγ, cone Tγ, and Gγ13 are shown. The penultimate 10 
residues are highly conserved, yet only Gγ13 is pulled down by GST-PrBP/δ 





	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 
 
 
